FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Costa, JO
   Barboza, RS
   Valente, LMM
   Wolff, T
   Gomes, M
   Gallo, B
   Berrueta, LA
   Guimaraes-Andrade, IP
   Gavino-Leopoldino, D
   Assuncao-Miranda, I
AF Costa, Jessica O.
   Barboza, Rodolfo S.
   Valente, Ligia M. M.
   Wolff, Thiago
   Gomes, Mario
   Gallo, Blanca
   Berrueta, Luis A.
   Guimaraes-Andrade, Iris P.
   Gavino-Leopoldino, Daniel
   Assuncao-Miranda, Iranaia
TI One-Step Isolation of Monoterpene Indole Alkaloids from Psychotria
   leiocarpa Leaves and Their Antiviral Activity on Dengue Virus Type-2
SO JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
LA English
DT Article
DE Psychotria leiocarpa; Rubiaceae; monoterpene indole alkaloids; phenolic
   compounds; solid-phase extraction; anti-dengue activity
ID N,BETA-D-GLUCOPYRANOSYL VINCOSAMIDE; PHENOLIC-COMPOUNDS;
   UNCARIA-TOMENTOSA; CONSTITUENTS
AB The leaf MeOH extract of Psychotria leiocarpa (Rubiaceae) showed in vitro non-cytotoxic and anti-dengue virus serotype 2 (DENV2) activity in human hepatocarcinoma cell lineage (HepG2). A one-step and cost-effective reversed-phase solid-phase extraction method based on high-performance liquid chromatography (HPLC) parameters allowed the isolation, directly from this bioactive extract, of the monoterpene indole alkaloids: N-glucopyranosyl vincosamide (1), vincosamide (2) and strictosidinic acid (3). The chemical structures were characterized based on 1D and 2D nuclear magnetic resonance (NMR), UV and high-resolution mass spectra (HRMS). The methodology has also allowed yielding a polyphenolic-rich fraction that was analyzed by high-performance liquid chromatography coupled to diode array detection and electrospray ionization tandem mass spectrometry (HPLC-DAD-ESI-MS/MS) revealing two fiavonol triglycosides (4, 5) and three caffeoylquinic acid isomers (6-8). Compound 3 is reported for the first time in P leiocarpa and all the phenolic compounds (4-8) are described for the first time in the genus Psychotria. Compounds 1-3 showed to be non-cytotoxic and anti-dengue active towards DENV2, highlighting vincosamide (2).
C1 [Costa, Jessica O.; Barboza, Rodolfo S.; Valente, Ligia M. M.; Wolff, Thiago] Univ Fed Rio de Janeiro, Ctr Tecnol, Inst Quim, Av Athos da Silveira Ramos 149,Bloco A, BR-21941909 Rio De Janeiro, RJ, Brazil.
   [Gomes, Mario] Inst Pesquisas Jardim Bot Rio de Janeiro, Inst Pesquisas, R Pacheco Leao 915, BR-22460030 Rio De Janeiro, RJ, Brazil.
   [Gallo, Blanca; Berrueta, Luis A.] Univ Basque Country, Euskal Herriko Unibertsitatea UPV EHU, Fac Ciencia & Tecnol, Dept Quim Analit, POB 644, Bilbao 48080, Spain.
   [Guimaraes-Andrade, Iris P.; Gavino-Leopoldino, Daniel; Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Ctr Ciencias Saude, Av Carlos Chagas Filho 373,Bloco 1, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Barboza, RS; Valente, LMM (corresponding author), Univ Fed Rio de Janeiro, Ctr Tecnol, Inst Quim, Av Athos da Silveira Ramos 149,Bloco A, BR-21941909 Rio De Janeiro, RJ, Brazil.
EM rodolfosb@iq.ufrj.br; valente@iq.ufrj.br
OI Gallo, Blanca/0000-0002-2421-9985
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ) [E-26/111.373/2014,
   E-26/203.225/2017]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES [001]; CAPESCAPES; FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ), processes No.
   E-26/111.373/2014 and E-26/203.225/2017. DGL and JOC thank Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), finance code
   001, for their fellowships. TW thanks both CAPES and FAPERJ for his
   fellowships. The authors thank the NMR Lab of the Instituto de Pesquisas
   em Produtos Naturais, Universidade Federal do Rio de Janeiro for the NMR
   spectra and MSc Matheus Oliveira, Dr Marcelo M. Pereira and Dr Denise
   Freire for their support. Technical and staff support provided by SGIker
   (UPV/EHU, MICINN, GV/EJ, ESF) is also gratefully acknowledged.
CR Abad-Garcia B, 2009, J CHROMATOGR A, V1216, P5398, DOI 10.1016/j.chroma.2009.05.039
   Andrade JMM, 2010, CHEM NAT COMPD+, V46, P649, DOI 10.1007/s10600-010-9702-6
   Barboza RS, 2018, CHEM BIODIVERS, V15, DOI 10.1002/cbdv.201700393
   Barboza RS, 2015, J LIQ CHROMATOGR R T, V38, P532, DOI 10.1080/10826076.2014.917666
   Calixto NO, 2016, J BRAZIL CHEM SOC, V27, P1355, DOI 10.5935/0103-5053.20160149
   Carvalho Jr. A.R, 2017, MOLECULES, V22, P2
   Clifford MN, 2005, J AGR FOOD CHEM, V53, P3821, DOI 10.1021/jf050046h
   Clifford MN, 2003, J AGR FOOD CHEM, V51, P2900, DOI 10.1021/jf026187q
   Clifford MN, 2002, METHODS IN POLYPHENOL ANALYSIS, P314
   Moraes TMD, 2011, PLANTA MED, V77, P964, DOI 10.1055/s-0030-1250656
   Delprete Piero Giuseppe, 2012, Rodriguésia, V63, P101, DOI 10.1590/S2175-78602012000100009
   Dighe SN, 2019, EUR J MED CHEM, V176, P431, DOI 10.1016/j.ejmech.2019.05.010
   Elisabetsky Elaine, 1997, Ciencia e Cultura (Sao Paulo), V49, P378
   Ferreira Junior Miguel, 2015, Hoehnea, V42, P289, DOI 10.1590/2236-8906-10/2015
   Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Henriques AT, 2004, PHYTOCHEMISTRY, V65, P449, DOI 10.1016/j.phytochem.2003.10.027
   Lima RS, 2013, NAT PROD COMMUN, V8, P1547
   Lopes S, 2004, BIOCHEM SYST ECOL, V32, P1187, DOI 10.1016/j.bse.2004.04.015
   Ma YL, 1997, RAPID COMMUN MASS SP, V11, P1357
   Matsuura HN, 2016, J NAT PROD, V79, P3006, DOI 10.1021/acs.jnatprod.6b00492
   Matsuura HN, 2016, IND CROP PROD, V86, P210, DOI 10.1016/j.indcrop.2016.03.050
   Matsuura HN, 2013, NAT PROD RES, V27, P402, DOI 10.1080/14786419.2012.715293
   Mello CD, 2017, MEM I OSWALDO CRUZ, V112, P458, DOI 10.1590/0074-02760160323
   Nascimento AC, 2017, PHYTOCHEM LETT, V19, P220, DOI 10.1016/j.phytol.2017.01.013
   Formagio ASN, 2019, INFLAMMATION, V42, P1561, DOI 10.1007/s10753-019-01018-w
   Formagio ASN, 2014, ANTIOXIDANTS-BASEL, V3, P745, DOI 10.3390/antiox3040745
   Newman DJ, 2020, J NAT PROD, V83, P770, DOI 10.1021/acs.jnatprod.9b01285
   Poole CF, 2003, TRAC-TREND ANAL CHEM, V22, P362, DOI 10.1016/S0165-9936(03)00605-8
   Reis SRIN, 2008, INT IMMUNOPHARMACOL, V8, P468, DOI 10.1016/j.intimp.2007.11.010
   SANGSTER AW, 1965, CHEM REV, V65, P69, DOI 10.1021/cr60233a003
   Secretaria de Vigilancia em Saude Ministerio da Saude do Brasil, 2020, B EPIDEMIOLOGICO, V51, P2020
   Simpson N. J. K., 2000, SOLID PHASE EXTRACTI
   Volobuff CRF, 2019, CURR PHARM BIOTECHNO, V20, P302, DOI 10.2174/1389201020666190211154550
   Wolff T, 2019, PHYTOCHEM ANALYSIS, V30, P62, DOI 10.1002/pca.2790
   World Health Organization, 2019, DENG SEV DENG
   Yang HM, 2016, CHEM BIODIVERS, V13, P807, DOI 10.1002/cbdv.201500259
NR 37
TC 0
Z9 0
U1 2
U2 2
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0103-5053
EI 1678-4790
J9 J BRAZIL CHEM SOC
JI J. Braz. Chem. Soc.
PD OCT
PY 2020
VL 31
IS 10
BP 2104
EP 2113
DI 10.21577/0103-5053.20200111
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA OA2PM
UT WOS:000577634100015
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Neris, RLS
   Chen, YH
   Davidyan, A
   Assuncao-Miranda, I
   Baar, K
   Bodine, S
   Gomes, A
AF Neris, Romulo
   Chen, Yu-Hsuen
   Davidyan, Arik
   Assuncao-Miranda, Iranaia
   Baar, Keith
   Bodine, Sue
   Gomes, Aldrin
TI TESTOSTERONE SUPPLEMENTATION LEADS TO INCREASED IMMUNOPROTEASOME
   ACTIVITY IN FEMALE BUT NOT MALE MICE
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Annual Meeting on Experimental Biology
CY APR 04-07, 2020
CL San Diego, CA
SP Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr, Amer Soc Pharmacol & Expt Therapeut
C1 [Neris, Romulo; Chen, Yu-Hsuen; Davidyan, Arik; Baar, Keith; Bodine, Sue; Gomes, Aldrin] Univ Calif Davis, Davis, CA 95616 USA.
   [Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2020
VL 34
SU 1
DI 10.1096/fasebj.2020.34.s1.07080
PG 2
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA MG5YS
UT WOS:000546107901190
DA 2020-12-01
ER

PT J
AU Figueiredo, CM
   Neris, RLD
   Gavino-Leopoldino, D
   da Silva, MOL
   Almeida, JS
   dos-Santos, JS
   Figueiredo, CP
   Bellio, M
   Bozza, MT
   Assuncao-Miranda, I
AF Figueiredo, Camila Menezes
   da Silva Neris, Romulo Leao
   Gavino-Leopoldino, Daniel
   Lopes da Silva, Mariana Oliveira
   Almeida, Juliana Silva
   dos-Santos, Julio Souza
   Figueiredo, Claudia Pinto
   Bellio, Maria
   Bozza, Marcelo Torres
   Assuncao-Miranda, Iranaia
TI Mayaro Virus Replication Restriction and Induction of Muscular
   Inflammation in Mice Are Dependent on Age, Type-I Interferon Response,
   and Adaptive Immunity
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE mayaro virus; pathogenesis; replication restriction; type-I interferon
   response; adaptive immunity; muscle inflammation
ID CHIKUNGUNYA VIRUS; INFECTION; ARTHRALGIA; ARTHRITIS; DISEASE;
   EXPRESSION; OUTBREAK; HUMANS; MODELS; BRAZIL
AB Mayaro virus (MAYV) is an emergent arbovirus first described in forest regions of the American continent, with recent and increasing notification of urban area circulation. Similar to Chikungunya (CHIKV) and other arthritogenic Alphavirus, MAYV-induced disease shows a high prevalence of persistent arthralgia, and myalgia. Despite this, knowledge regarding pathogenesis and characteristics of host immune response of MAYV infections are still limited. Here, using different ages of wild-type (WT), adult Type I Interferon receptor deficient (IFNAR(-/-)), and adult recombination activation gene-1 deficient (RAG(-/-)) mice, we have investigated the dependence of age, innate and adaptive immunity for the control of MAYV replication, tissue damage, and inflammation in mice. We have found that MAYV induces clinical signal and replicates in young WT mice, which gain the ability to restrict MAYV replication with aging. In addition, we observed that mice age and type I interferon response are related to restriction of MAYV infection and muscular inflammation in mice. Moreover, MAYV continues to replicate persistently in RAG(-/-) mice, being detected at blood and tissues 40 days post infection, indicating that adaptive immunity is essential to MAYV clearance. Despite chronic replication, infected adult RAG(-/-) mice did not develop an apparent signal of muscle damage in early and late infection. On the other hand, MAYV infection in young WT and adult IFNAR-/- mice triggers an increase in the expression of pro-inflammatory mediators, such as TNF, IL-6, KC, IL-1 beta, MCP-1, and RANTES, in muscle tissue, and decreases TGF-beta expression, that were not significantly modulated in adult WT and RAG(-/-) mice. Taken together, our data demonstrated that age, innate and adaptive immunity are important to restrict MAYV replication and that adaptive immunity is also involved in MAYV-induced tissue damage. These results contribute to the comprehension of MAYV pathogenesis, and describe translational mice models for further studies of MAYV infection, vaccine tests, and therapeutic strategies against this virus.
C1 [Figueiredo, Camila Menezes; da Silva Neris, Romulo Leao; Gavino-Leopoldino, Daniel; Lopes da Silva, Mariana Oliveira; Almeida, Juliana Silva; dos-Santos, Julio Souza; Bellio, Maria; Bozza, Marcelo Torres; Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.
   [Figueiredo, Claudia Pinto] Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil.
RP Assuncao-Miranda, I (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.
EM iranaiamiranda@micro.ufrj.br
RI Santos, Julio/AAN-4394-2020; BELLIO, MARIA/N-8525-2018
OI Souza dos Santos, Julio/0000-0002-1165-4232; BELLIO,
   MARIA/0000-0002-3360-2740
FU Brazilian funding agency: Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support
   of the State of Rio de Janeiro (FAPERJ); Brazilian funding agency:
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Brazilian funding agency: Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)CAPES [001]
FX This work was supported by grants from the Brazilian funding agencies:
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ),
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   finance Code 001.
CR Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394
   Esposito DLA, 2017, BRAZ J INFECT DIS, V21, P540, DOI 10.1016/j.bjid.2017.06.002
   Assuncao-Miranda I, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/973516
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Brehin AC, 2009, VIROLOGY, V384, P216, DOI 10.1016/j.virol.2008.10.021
   Brunini S, 2017, EMERG INFECT DIS, V23, P1025, DOI 10.3201/eid2306.160929
   Caldas LA, 2018, REV SOC BRAS MED TRO, V51, P584, DOI 10.1590/0037-8682-0235-2018
   Camini FC, 2017, VIRUS RES, V236, P1, DOI 10.1016/j.virusres.2017.04.017
   Carissimo G, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900298
   Cavalheiro MG, 2016, AN ACAD BRAS CIENC, V88, P1485, DOI 10.1590/0001-3765201620150685
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   da Costa VG, 2017, INT J INFECT DIS, V62, P84, DOI 10.1016/j.ijid.2017.07.016
   Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180
   Fros JJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060166
   Ganesan VK, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120368
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Haese NN, 2016, J INFECT DIS, V214, pS482, DOI 10.1093/infdis/jiw284
   Haist KC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006748
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   Hawman DW, 2013, J VIROL, V87, P13878, DOI 10.1128/JVI.02666-13
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Kelvin AA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001279
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lewthwaite P, 2009, EMERG INFECT DIS, V15, P329, DOI 10.3201/eid1502.080902
   Lidbury BA, 2008, J INFECT DIS, V197, P1585, DOI 10.1086/587841
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Alves EDL, 2018, VIRUS RES, V256, P166, DOI 10.1016/j.virusres.2018.08.011
   Mackay IM, 2016, MICROBES INFECT, V18, P724, DOI 10.1016/j.micinf.2016.10.007
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G
   Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006
   Murillo-Zamora E, 2018, ARCH MED RES, V49, P65, DOI 10.1016/j.arcmed.2018.04.008
   Ng LFP, 2017, ANNU REV VIROL, V4, P413, DOI 10.1146/annurev-virology-101416-041808
   Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261
   Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527
   Poddar S, 2016, J VIROL, V90, P8780, DOI 10.1128/JVI.00655-16
   Santiago FW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004104
   Santos FM, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007375
   Seymour RL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003800
   Slegers CAD, 2014, J CLIN VIROL, V60, P317, DOI 10.1016/j.jcv.2014.04.020
   Smith JL, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00003-18, 10.1128/msphere.00003-18]
   Soden M, 2000, ARTHRITIS RHEUM, V43, P365, DOI 10.1002/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E
   Tappe D, 2017, EMERG INFECT DIS, V23, P702, DOI 10.3201/eid2304.160466
   Taylor A, 2015, J GEN VIROL, V96, P221, DOI 10.1099/vir.0.071282-0
   Taylor SF, 2005, SOUTH MED J, V98, P484, DOI 10.1097/01.SMJ.0000145879.14102.F4
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   Theilacker C, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-369
   Uhrlaub JL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005891
   Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006
   Zhang XM, 2017, NAT REV IMMUNOL, V17, P495, DOI 10.1038/nri.2017.54
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 53
TC 4
Z9 4
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD OCT 1
PY 2019
VL 10
AR 2246
DI 10.3389/fmicb.2019.02246
PG 11
WC Microbiology
SC Microbiology
GA JF3GS
UT WOS:000491274900001
PM 31632368
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Figueiredo, CP
   Barros-Aragao, FGQ
   Neris, RLS
   Frost, PS
   Soares, C
   Souza, INO
   Zeidler, JD
   Zamberlan, DC
   de Sousa, VL
   Souza, AS
   Guimaraes, ALA
   Bellio, M
   de Souza, JM
   Alves-Leon, SV
   Neves, GA
   Paula-Neto, HA
   Castro, NG
   De Felice, FG
   Assuncao-Miranda, I
   Clarke, JR
   Da Poian, AT
   Ferreira, ST
AF Figueiredo, Claudia P.
   Barros-Aragao, Fernanda G. Q.
   Neris, Romulo L. S.
   Frost, Paula S.
   Soares, Carolina
   Souza, Isis N. O.
   Zeidler, Julianna D.
   Zamberlan, Daniele C.
   de Sousa, Virginia L.
   Souza, Amanda S.
   Guimaraes, Andre Luis A.
   Bellio, Maria
   de Souza, Jorge Marcondes
   Alves-Leon, Soniza V.
   Neves, Gilda A.
   Paula-Neto, Heitor A.
   Castro, Newton G.
   De Felice, Fernanda G.
   Assuncao-Miranda, Iranaia
   Clarke, Julia R.
   Da Poian, Andrea T.
   Ferreira, Sergio T.
TI Zika virus replicates in adult human brain tissue and impairs synapses
   and memory in mice
SO NATURE COMMUNICATIONS
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; A-BETA OLIGOMERS; ACTIVATION; INFECTION;
   COMPLICATIONS; MICROGLIA; EPIDEMIC; DISEASE; IMPACT
AB Neurological complications affecting the central nervous system have been reported in adult patients infected by Zika virus (ZIKV) but the underlying mechanisms remain unknown. Here, we report that ZIKV replicates in human and mouse adult brain tissue, targeting mature neurons. ZIKV preferentially targets memory-related brain regions, inhibits hippocampal long-term potentiation and induces memory impairment in adult mice. TNF-alpha upregulation, microgliosis and upregulation of complement system proteins, C1q and C3, are induced by ZIKV infection. Microglia are found to engulf hippocampal presynaptic terminals during acute infection. Neutralization of TNF-alpha signaling, blockage of microglial activation or of C1q/C3 prevent synapse and memory impairment in ZIKV-infected mice. Results suggest that ZIKV induces synapse and memory dysfunction via aberrant activation of TNF-alpha, microglia and complement. Our findings establish a mechanism by which ZIKV affects the adult brain, and point to the need of evaluating cognitive deficits as a potential comorbidity in ZIKV-infected adults.
C1 [Figueiredo, Claudia P.; Barros-Aragao, Fernanda G. Q.; Frost, Paula S.; Soares, Carolina; Souza, Isis N. O.; Zamberlan, Daniele C.; de Sousa, Virginia L.; Guimaraes, Andre Luis A.; Paula-Neto, Heitor A.; Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Barros-Aragao, Fernanda G. Q.; Frost, Paula S.; Soares, Carolina; Neves, Gilda A.; Castro, Newton G.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Neris, Romulo L. S.; Bellio, Maria; Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Zeidler, Julianna D.; De Felice, Fernanda G.; Da Poian, Andrea T.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Souza, Amanda S.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [de Souza, Jorge Marcondes; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Div Neurosurg, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [de Souza, Jorge Marcondes; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Epilepsy Program, Div Neurol, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza V.] Queens Univ, Fed Univ Rio de Janeiro State, Grad Program Neurol, Kingston, ON, Canada.
   [De Felice, Fernanda G.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.
   [De Felice, Fernanda G.] Queens Univ, Dept Psychiat, Kingston, ON, Canada.
RP Figueiredo, CP (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.; Da Poian, AT; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM claudia@pharma.ufrj.br; dapoian@bioqmed.ufrj.br;
   ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; de Oliveira Souza, Isis
   Nem/AAA-3423-2019; Clarke, Julia/AAF-9434-2019; Neves, Gilda
   A./K-7573-2012; Castro, Newton G/C-3263-2009; BELLIO, MARIA/N-8525-2018
OI Ferreira, Sergio/0000-0001-7160-9866; de Oliveira Souza, Isis
   Nem/0000-0002-0335-2541; Neves, Gilda A./0000-0002-7027-3851; Castro,
   Newton G/0000-0001-9570-7428; BELLIO, MARIA/0000-0002-3360-2740; da
   Silva Frost, Paula/0000-0002-3814-999X; Zeidler, Julianna
   D./0000-0003-3168-1518; Gomes de Queiroz Barros-Aragao,
   Fernanda/0000-0002-1663-8346; Souza, Amanda/0000-0002-7561-8150
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Alves-Leon SV, 2019, MULT SCLER J, V25, P427, DOI 10.1177/1352458518781992
   Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018
   Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bellesi M, 2017, J NEUROSCI, V37, P5263, DOI 10.1523/JNEUROSCI.3981-16.2017
   Bido-Medina R, 2018, ANN CLIN TRANSL NEUR, V5, P752, DOI 10.1002/acn3.575
   Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Ennaceur A, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.223
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Ferreira J, 2005, PAIN, V117, P171, DOI 10.1016/j.pain.2005.06.001
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Figueiredo CP, 2011, J ALZHEIMERS DIS, V24, P61, DOI 10.3233/JAD-2010-101320
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Gonzalez-Dunia D, 2000, J VIROL, V74, P3441, DOI 10.1128/JVI.74.8.3441-3448.2000
   Greter M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00249
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14
   Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54
   Kuno R, 2005, J NEUROIMMUNOL, V162, P89, DOI 10.1016/j.jneuroim.2005.01.015
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Mamik MK, 2016, J NEUROSCI, V36, P10683, DOI 10.1523/JNEUROSCI.1287-16.2016
   Matheus FC, 2016, MOL NEUROBIOL, V53, P3891, DOI 10.1007/s12035-015-9330-z
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Nazerai L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00593
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Piacentini R, 2015, SCI REP-UK, V5, DOI 10.1038/srep15444
   Presumey J, 2017, ADV IMMUNOL, V135, P53, DOI 10.1016/bs.ai.2017.06.004
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Risher WC, 2014, ELIFE, V3, DOI 10.7554/eLife.04047
   Ronca SE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00959
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Souza INO, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020060
   STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203
   Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036
   Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14
   Torres-Platas SG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-12
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
   World Health Organization, 2017, ZIK VIR MICR GUILL B
NR 59
TC 20
Z9 20
U1 2
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD SEP 5
PY 2019
VL 10
AR 3890
DI 10.1038/s41467-019-11866-7
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IU9SV
UT WOS:000483921700001
PM 31488835
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Souza, INDO
   Frost, P
   Franca, J
   Nascimento-Viana, J
   Neris, R
   Nogueira, C
   Neves, G
   Chimelli, L
   De-Felice, F
   Ferreira, S
   Assuncao-Miranda, I
   Figueiredo, C
   Poian, AD
   Clarke, J
AF Souza, I. N. D. O.
   Frost, P.
   Franca, J.
   Nascimento-Viana, J.
   Neris, R.
   Nogueira, C.
   Neves, G.
   Chimelli, L.
   De-Felice, F.
   Ferreira, S.
   Assuncao-Miranda, I.
   Figueiredo, C.
   Poian, A. D.
   Clarke, J.
TI Acute and chronic neurological consequences of neonatal zika virus
   infection in mice
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-Neurochemistry and
   American-Society-for-Neurochemistry (ISN-ASN)
CY AUG 04-08, 2019
CL Montreal, CANADA
SP Int Soc Neurochemistry, Amer Soc Neurochemistry
C1 [Souza, I. N. D. O.; Frost, P.; Nascimento-Viana, J.; Nogueira, C.; Figueiredo, C.; Clarke, J.] Univ Fed Rio de Janeiro, Fac Pharm, Rio De Janeiro, Brazil.
   [Frost, P.; Franca, J.; Neves, G.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Neris, R.; Assuncao-Miranda, I.] Univ Fed Rio de Janeiro, Inst Microbiol, Rio De Janeiro, Brazil.
   [Chimelli, L.] State Inst Brain, Neuropathol Lab, Rio De Janeiro, Brazil.
   [De-Felice, F.; Ferreira, S.; Poian, A. D.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
   [De-Felice, F.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.
   [Ferreira, S.] Univ Fed Rio de Janeiro, Inst Biophys, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD JUL
PY 2019
VL 150
SU 1
SI SI
MA MTU05-06
BP 105
EP 105
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA IN4IY
UT WOS:000478639800238
DA 2020-12-01
ER

PT J
AU Wolff, T
   Berrueta, LA
   Valente, LMM
   Barboza, RS
   Neris, RLS
   Guimaraes-Andrade, IP
   Assuncao-Miranda, I
   Nascimento, AC
   Gomes, M
   Gallo, B
   Iriondo, C
AF Wolff, Thiago
   Berrueta, Luis A.
   Valente, Ligia M. M.
   Barboza, Rodolfo S.
   Neris, Romulo L. S.
   Guimaraes-Andrade, Iris P.
   Assuncao-Miranda, Iranaia
   Nascimento, Adriana C.
   Gomes, Mario
   Gallo, Blanca
   Iriondo, Carmen
TI Comprehensive characterisation of polyphenols in leaves and stems of
   three anti-dengue virus type-2 active Brazilian Faramea species
   (Rubiaceae) by HPLC-DAD-ESI-MS/MS
SO PHYTOCHEMICAL ANALYSIS
LA English
DT Article
DE anti-dengue activity; Faramea; dengue virus; HPLC-DAD-ESI-MS; MS;
   polyphenols; Rubiaceae
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; C-GLYCOSYL FLAVONES;
   ELECTROSPRAY-IONIZATION; FLAVANONE GLYCOSIDES; PHENOLIC-COMPOUNDS;
   NATURAL-PRODUCTS; DIFFERENTIATION; CONSTITUENTS; ANTIOXIDANT; PLANTS
AB IntroductionThe methanol (MeOH) leaf extracts of the species Faramea bahiensis, F. hyacinthina and F. truncata (Rubiaceae) have previously shown in vitro non-cytotoxic and anti-dengue virus serotype 2 (DENV2) activities in human hepatocarcinoma cell lineage (HepG2). Chemical studies have led to the isolation of major flavonoids, but quite complex fractions of phenolic compounds still remain.
   ObjectiveTo complete the study of phenolic compounds in the leaves and to access the presence of these compounds in the stems of these Faramea spp. by online high-performance liquid chromatography-diode array detector-electrospray ionisation tandem mass spectrometry (HPLC-DAD-ESI-MS/MS), as well as to evaluate the in vitro cytotoxic and anti-DENV2 activities of their MeOH stem extracts.
   MethodologyThe identification was performed by comparing retention times, UV and mass spectra with those of available standards and by using the mechanisms and fragmentation patterns established in previous studies. The effects of the extracts in DENV2 infected HepG2 cell viability was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The virus titer was quantified by plaque assay.
   ResultsThe study led to the characterisation of 31 phenolic compounds including flavonoid O- and C-glycosides, phenolic acids and one coumarin. The stem extracts from F. hyacinthina and F. bahiensis presented a similar bioactivity to those of their leaves but a loss of cytoprotective activity of F. bahiensis and a higher cytotoxicity of F. truncata were observed.
   ConclusionsThis research allowed a detailed phenolic composition of three bioactive Faramea species to be achieved, thus contributing to the study of this genus and providing valuable information for further phytotherapeutic applications.
   The presence of 31 phenolic compounds in leaves and stems of Faramea bahiensis, F. hyacinthina and F. truncata was achieved by HPLC-DAD-ESI-MS/MS. In addition to the previously reported non-cytotoxicity and anti-dengue activity of their leaves, an evaluation of these properties in their stems showed that F. hyacinthina and F. bahiensis stems presented a similar bioactivity to those of their leaves but a loss of cytoprotection of F. bahiensis and a higher cytotoxicity of F. truncata were observed.
C1 [Wolff, Thiago; Valente, Ligia M. M.; Barboza, Rodolfo S.; Nascimento, Adriana C.] Univ Fed Rio de Janeiro, Inst Quim, Rio De Janeiro, Brazil.
   [Berrueta, Luis A.; Gallo, Blanca] Univ Basque Country, Fac Ciencia & Tecnol, Dept Quim Analit, POB 644, E-48080 Bilbao, Spain.
   [Neris, Romulo L. S.; Guimaraes-Andrade, Iris P.; Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil.
   [Gomes, Mario] Inst Pesquisas Jardim Bot Rio De Janeiro, Rio De Janeiro, Brazil.
   [Iriondo, Carmen] Univ Basque Country, Fac Ciencia & Tecnol, Dept Quim Organ, Bilbao, Spain.
RP Berrueta, LA (corresponding author), Univ Basque Country, Fac Ciencia & Tecnol, Dept Quim Analit, POB 644, E-48080 Bilbao, Spain.; Valente, LMM (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, Ctr Tecnol, Av Athos da Silveira Ramos 149,Bl A,Cidade Univ, BR-21941909 Rio De Janeiro, RJ, Brazil.
EM luisangel.berrueta@ehu.es; valente@iq.ufrj.br
RI Barboza, Rodolfo/AAR-3950-2020; Valente, Ligia M M/F-3405-2014
OI Barboza, Rodolfo/0000-0002-7098-2447; Valente, Ligia M
   M/0000-0003-3195-8927; Gallo, Blanca/0000-0002-2421-9985
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ-Brazil)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/111.373/2014]
FX Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ-Brazil), Grant/Award Number: E-26/111.373/2014
CR Abad-Garcia B, 2007, J CHROMATOGR A, V1154, P87, DOI 10.1016/j.chroma.2007.03.023
   Abad-Garcia B, 2008, RAPID COMMUN MASS SP, V22, P1834, DOI 10.1002/rcm.3560
   Abad-Garcia B, 2009, J CHROMATOGR A, V1216, P5398, DOI 10.1016/j.chroma.2009.05.039
   Abd Kadir SL, 2013, J NAT MED-TOKYO, V67, P677, DOI 10.1007/s11418-013-0767-y
   Abu-Reidah IM, 2012, FOOD RES INT, V46, P108, DOI 10.1016/j.foodres.2011.11.026
   Barboza RS, 2018, CHEM BIODIVERS, V15, DOI 10.1002/cbdv.201700393
   Brazilian Federal Government, 2017, B EPIDEMIOLOGICO, V48, P1
   Bucar F, 1998, PHYTOCHEMISTRY, V48, P573, DOI 10.1016/S0031-9422(98)00048-X
   Calis I, 2008, NAT PROD COMMUN, V3, P117
   Cao JG, 2013, FOOD CHEM TOXICOL, V55, P121, DOI 10.1016/j.fct.2012.12.051
   Cavaliere C, 2005, RAPID COMMUN MASS SP, V19, P3143, DOI 10.1002/rcm.2185
   Chicca A, 2011, EUR J MED CHEM, V46, P3066, DOI 10.1016/j.ejmech.2011.03.011
   Coulerie P, 2013, PLANTA MED, V79, P1313, DOI 10.1055/s-0033-1350672
   DOMON B, 1988, BIOCHEMISTRY-US, V27, P1534, DOI 10.1021/bi00405a021
   Farooq MO, 1953, J SCI IND RES B PH S, V12B, P400
   FERRARI F, 1985, PHYTOCHEMISTRY, V24, P2753, DOI 10.1016/S0031-9422(00)80719-0
   Ferreres F, 2007, J CHROMATOGR A, V1161, P214, DOI 10.1016/j.chroma.2007.05.103
   Ferreres F, 2003, PHYTOCHEM ANALYSIS, V14, P352, DOI 10.1002/pca.727
   Frabasile S, 2017, SCI REP-UK, V7, DOI 10.1038/srep41864
   de Sousa LRF, 2015, BIOORGAN MED CHEM, V23, P466, DOI 10.1016/j.bmc.2014.12.015
   Gil-Izquierdo A, 2004, J AGR FOOD CHEM, V52, P324, DOI 10.1021/jf0304775
   Guo C, 2017, FRONT CELL INFECT MI, V7, P1
   HORI K, 1988, YAKUGAKU ZASSHI, V108, P417, DOI 10.1248/yakushi1947.108.5_417
   Jardim JG, 2008, NOVON, V18, P67, DOI 10.3417/2006182
   JAY M, 2006, FLAVONOIDS CHEM BIOC
   KANEKO T, 1995, PHYTOCHEMISTRY, V39, P115, DOI 10.1016/0031-9422(94)00884-V
   Keivan Zandi, 2014, Journal of Medicinal Plants Research, V8, P307
   Khattab AA, 2007, B FAC PHARM CAIRO, V45, P181
   La MP, 2015, J PHARMACEUT BIOMED, V102, P366, DOI 10.1016/j.jpba.2014.09.038
   Li YL, 2008, MOLECULES, V13, P1931, DOI 10.3390/molecules13081931
   Ma YL, 2000, J AM SOC MASS SPECTR, V11, P136, DOI 10.1016/S1044-0305(99)00133-6
   Ma YL, 1997, RAPID COMMUN MASS SP, V11, P1357
   March RE, 2006, INT J MASS SPECTROM, V248, P61, DOI 10.1016/j.ijms.2005.09.011
   Markham KR, 1982, TECHNIQUES FLAVONOID
   Masuoka C, 2003, FOOD SCI TECHNOL RES, V9, P197, DOI 10.3136/fstr.9.197
   Moghaddam E, 2014, SCI REP-UK, V4, DOI 10.1038/srep05452
   Nascimento AC, 2017, PHYTOCHEM LETT, V19, P220, DOI 10.1016/j.phytol.2017.01.013
   Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055
   Picerno P, 2003, J AGR FOOD CHEM, V51, P6423, DOI 10.1021/jf030284h
   Ribeiro AF, 2003, CBO 013 ESTACAO CIEN
   SAUVAIN M, 1994, J NAT PROD, V57, P403, DOI 10.1021/np50105a014
   Siciliano T, 2004, J AGR FOOD CHEM, V52, P6510, DOI 10.1021/jf040214q
   Srivarangkul P, 2018, ANTIVIR RES, V151, P27, DOI 10.1016/j.antiviral.2018.01.010
   Takahashi H, 2001, PHYTOCHEMISTRY, V56, P875, DOI 10.1016/S0031-9422(00)00493-3
   Teixeira RR, 2014, MOLECULES, V19, P8151, DOI 10.3390/molecules19068151
   Wanjala CCW, 1999, PHYTOCHEMISTRY, V51, P705, DOI 10.1016/S0031-9422(99)00065-5
   Waridel P, 2001, J CHROMATOGR A, V926, P29, DOI 10.1016/S0021-9673(01)00806-8
   WHO, 2017, DENG SEV DENG
   Zhang ZZ, 2003, J NAT PROD, V66, P39, DOI 10.1021/np020429z
NR 49
TC 3
Z9 3
U1 3
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0958-0344
EI 1099-1565
J9 PHYTOCHEM ANALYSIS
JI Phytochem. Anal.
PD JAN-FEB
PY 2019
VL 30
IS 1
BP 62
EP 72
DI 10.1002/pca.2790
PG 11
WC Biochemical Research Methods; Plant Sciences; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Plant Sciences; Chemistry
GA HK6KW
UT WOS:000458089000006
PM 30191624
DA 2020-12-01
ER

PT J
AU Neris, RLS
   Figueiredo, CM
   Higa, LM
   Araujo, DF
   Carvalho, CAM
   Vercoza, BRF
   Silva, MOL
   Carneiro, FA
   Tanuri, A
   Gomes, AMO
   Bozza, MT
   Da Poian, AT
   Cruz-Oliveira, C
   Assuncao-Miranda, I
AF Neris, Romulo L. S.
   Figueiredo, Camila M.
   Higa, Luiza M.
   Araujo, Daniel F.
   Carvalho, Carlos A. M.
   Vercoza, Brunno R. F.
   Silva, Mariana O. L.
   Carneiro, Fabiana A.
   Tanuri, Amilcar
   Gomes, Andre M. O.
   Bozza, Marcelo T.
   Da Poian, Andrea T.
   Cruz-Oliveira, Christine
   Assuncao-Miranda, Iranaia
TI Co-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika,
   Chikungunya and other arboviruses by targeting the viral envelope
SO SCIENTIFIC REPORTS
LA English
DT Article
ID TIN-PROTOPORPHYRIN; ANTIVIRAL ACTIVITY; HEME OXYGENASE-1; VIRUSES;
   FUSION; DENGUE; MONOXIDE; AMERICA; COINFECTION; COLOMBIA
AB The global situation of diseases transmitted by arthropod-borne viruses such as Dengue (DENV), Yellow Fever (YFV), Chikungunya (CHIKV) and Zika (ZIKV) viruses is alarming and treatment of human infection by these arboviruses faces several challenges. The discovery of broad-spectrum antiviral molecules, able to inactivate different groups of viruses, is an interesting approach. The viral envelope is a common structure among arboviruses, being a potential target for antivirals. Porphyrins are amphipathic molecules able to interact with membranes and absorb light, being widely used in photodynamic therapy. Previously, we showed that heme, Co-protoporphyrin IX (CoPPIX) and Sn-protoporphyrin IX (SnPPIX) directly inactivate DENV and YFV infectious particles. Here we demonstrate that the antiviral activity of these porphyrins can be broadened to CHIKV, ZIKV, Mayaro virus, Sindbis virus and Vesicular Stomatitis virus. Porphyrin treatment causes viral envelope protein loss, affecting viral morphology, adsorption and entry into target cells. Also, light-stimulation enhanced the SnPPIX activity against all tested arboviruses. In summary, CoPPIX and SnPPIX were shown to be efficient broad-spectrum compounds to inactivate medically and veterinary important viruses.
C1 [Neris, Romulo L. S.; Figueiredo, Camila M.; Araujo, Daniel F.; Silva, Mariana O. L.; Bozza, Marcelo T.; Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro UFRJ, Ctr Ciencias Saude, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.
   [Carvalho, Carlos A. M.; Gomes, Andre M. O.; Da Poian, Andrea T.; Cruz-Oliveira, Christine] Univ Fed Rio de Janeiro UFRJ, Ctr Ciencias Saude, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Higa, Luiza M.; Tanuri, Amilcar] Univ Fed Rio de Janeiro UFRJ, Inst Biol, Rio De Janeiro, Brazil.
   [Vercoza, Brunno R. F.; Carneiro, Fabiana A.] Univ Fed Rio de Janeiro UFRJ, Polo Avancado Xerem, NUMPEX Nucleo Multidisciplinar Pesquisas, Duque De Caxias, RJ, Brazil.
   [Carvalho, Carlos A. M.] Inst Evandro Chagas IEC, Secao Arbovirol & Febres Hemorrag, Ananindeua, PA, Brazil.
   [Carvalho, Carlos A. M.] Univ Estado Para UEPA, Ctr Ciencias Biol & Saude, Dept Morfol & Ciencias Fisiol, Belem, Para, Brazil.
RP Assuncao-Miranda, I (corresponding author), Univ Fed Rio de Janeiro UFRJ, Ctr Ciencias Saude, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.; Cruz-Oliveira, C (corresponding author), Univ Fed Rio de Janeiro UFRJ, Ctr Ciencias Saude, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.
EM ccruz@bioqmed.ufrj.br; iranaiamiranda@micro.ufrj.br
RI CARNEIRO, FABIANA A/S-4525-2018; Gomes, Andre/C-4009-2014; Da Poian,
   Andrea T./V-1699-2019; Vercoza, Brunno Renato Farias/AAB-4725-2019;
   Higa, Luiza/W-2698-2019
OI Gomes, Andre/0000-0003-1052-8004; Vercoza, Brunno Renato
   Farias/0000-0001-6117-7879; Cruz-Oliveira,
   Christine/0000-0003-4838-0703; Carneiro, Fabiana/0000-0002-6584-4875;
   Carvalho, Carlos/0000-0001-6615-1387
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES; Financiadora de Estudos e ProjetosCiencia Tecnologia e
   Inovacao (FINEP)
FX This work was supported by grants from Brazilian funding agencies:
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior and Financiadora de Estudos
   e Projetos.
CR Akamatsu Y, 2004, FASEB J, V18, P771, DOI 10.1096/fj.03-0921fje
   ANDERSON KE, 1986, CLIN PHARMACOL THER, V39, P510, DOI 10.1038/clpt.1986.88
   Assuncao-Miranda I, 2016, J APPL MICROBIOL, V120, P790, DOI 10.1111/jam.13038
   Bonnett R, 1989, CIBA F SYMP, V146, P40
   Bonnett R, 1989, AM J HYG, V146, P40
   Boriskin YS, 2008, CURR MED CHEM, V15, P997, DOI 10.2174/092986708784049658
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardona-Ospina JA, 2015, T ROY SOC TROP MED H, V109, P793, DOI 10.1093/trstmh/trv094
   Cruz-Oliveira C, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00053-17
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DRUMMOND GS, 1986, J CLIN INVEST, V77, P971, DOI 10.1172/JCI112398
   Espinoza JA, 2017, AM J PATHOL, V187, P487, DOI 10.1016/j.ajpath.2016.11.011
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Man D, 2011, J BIOL INORG CHEM, V16, P173, DOI 10.1007/s00775-010-0715-1
   Mardekian SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/834371
   Matanic VCA, 2004, INT J ANTIMICROB AG, V23, P382, DOI 10.1016/j.ijantimicag.2003.07.022
   McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Notario-Perez F, 2017, DRUG DES DEV THER, V11, P1767, DOI 10.2147/DDDT.S133170
   Olivia Lwande Wesula, 2015, Infection Ecology & Epidemiology, V5, P29853, DOI 10.3402/iee.v5.29853
   Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586
   Pushpan S. K., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P187, DOI 10.2174/1568011023354137
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005
   Sample CJ, 2013, PEPTIDES, V48, P96, DOI 10.1016/j.peptides.2013.07.014
   Silva P, 2010, PHOTOCHEM PHOTOBIOL, V86, P1147, DOI 10.1111/j.1751-1097.2010.00764.x
   Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197
   Sousa IP, 2011, J BIOL CHEM, V286, P1730, DOI 10.1074/jbc.M110.198002
   St Vincent MR, 2010, P NATL ACAD SCI USA, V107, P17339, DOI 10.1073/pnas.1010026107
   Stojiljkovic I, 2001, EXPERT OPIN INV DRUG, V10, P309, DOI 10.1517/13543784.10.2.309
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Vigant F, 2015, NAT REV MICROBIOL, V13, P426, DOI 10.1038/nrmicro3475
   Vigant F, 2014, J VIROL, V88, P1849, DOI 10.1128/JVI.02907-13
   Vigant F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003297
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WHO, 2017, DENG CONTR EP
   Wolf MC, 2010, P NATL ACAD SCI USA, V107, P3157, DOI 10.1073/pnas.0909587107
   World Health Organization, 2017, EM ZIK SIT REP
   Zhao HJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22008
   Zhu JD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00517
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 44
TC 11
Z9 11
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 28
PY 2018
VL 8
AR 9805
DI 10.1038/s41598-018-27855-7
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GK9FC
UT WOS:000436546200026
PM 29955082
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Souza, IND
   Frost, PS
   Franca, JV
   Nascimento-Viana, JB
   Neris, RLS
   Freitas, L
   Pinheiro, DJLL
   Nogueira, CO
   Neves, G
   Chimelli, L
   De Felice, FG
   Cavalheiro, EA
   Ferreira, ST
   Assuncao-Miranda, I
   Figueiredo, CP
   Da Poian, AT
   Clarke, JR
AF de Oliveira Souza, Isis Nem
   Frost, Paula S.
   Franca, Julia V.
   Nascimento-Viana, Jessica B.
   Neris, Romulo L. S.
   Freitas, Leandro
   Pinheiro, Daniel J. L. L.
   Nogueira, Clara O.
   Neves, Gilda
   Chimelli, Leila
   De Felice, Fernanda G.
   Cavalheiro, Esper A.
   Ferreira, Sergio T.
   Assuncao-Miranda, Iranaia
   Figueiredo, Claudia P.
   Da Poian, Andrea T.
   Clarke, Julia R.
TI Acute and chronic neurological consequences of early-life Zika virus
   infection in mice
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID NEUROPSYCHIATRIC DISORDERS; OXIDATIVE STRESS; CASE SERIES; BRAZIL;
   BRAIN; SEIZURES; INFANTS; GROWTH; HIPPOCAMPUS; INDUCTION
AB Although congenital Zika virus (ZIKV) exposure has been associated with microcephaly and other neurodevelopmental disorders, long-term consequences of perinatal infection are largely unknown. We evaluated short-and long-term neuropathological and behavioral consequences of neonatal ZIKV infection in mice. ZIKV showed brain tropism, causing postnatal-onset microcephaly and several behavioral deficits in adulthood. During the acute phase of infection, mice developed frequent seizures, which were reduced by tumor necrosis factor-alpha (TNF-alpha) inhibition. During adulthood, ZIKV replication persisted in neonatally infected mice, and the animals showed increased susceptibility to chemically induced seizures, neurodegeneration, and brain calcifications. Altogether, the results show that neonatal ZIKV infection has long-term neuropathological and behavioral complications in mice and suggest that early inhibition of TNF-alpha-mediated neuroinflammation might be an effective therapeutic strategy to prevent the development of chronic neurological abnormalities.
C1 [de Oliveira Souza, Isis Nem; Frost, Paula S.; Nascimento-Viana, Jessica B.; Nogueira, Clara O.; Figueiredo, Claudia P.; Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Frost, Paula S.; Franca, Julia V.; Neves, Gilda] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Neris, Romulo L. S.; Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Freitas, Leandro; Pinheiro, Daniel J. L. L.; Cavalheiro, Esper A.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Neurol & Neurosurg, BR-04023062 Sao Paulo, SP, Brazil.
   [Chimelli, Leila] State Inst Brain Paulo Niemeyer, Lab Neuropathol, Rio De Janeiro, Brazil.
   [De Felice, Fernanda G.; Ferreira, Sergio T.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Figueiredo, CP; Clarke, JR (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.; Assuncao-Miranda, I (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21944590 Rio De Janeiro, RJ, Brazil.; Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM iranaiamiranda@micro.ufrj.br; claufig@gmail.com;
   dapoian@bioqmed.ufrj.br; juliaclarke@pharma.ufrj.br
RI Clarke, Julia/AAF-9434-2019; Ferreira, Sergio/AAZ-1576-2020; Figueiredo,
   Claudia P/F-8424-2012; Neves, Gilda A./K-7573-2012; de Oliveira Souza,
   Isis Nem/AAA-3423-2019; Cavalheiro, Esper A/I-3084-2016; Cavalheiro,
   Esper/N-3985-2019; Neves, Gilda A./U-1622-2019; Da Poian, Andrea
   T./V-1699-2019
OI Ferreira, Sergio/0000-0001-7160-9866; Neves, Gilda
   A./0000-0002-7027-3851; de Oliveira Souza, Isis Nem/0000-0002-0335-2541;
   Cavalheiro, Esper A/0000-0002-0854-3582; Cavalheiro,
   Esper/0000-0002-0854-3582; Pinheiro, Daniel/0000-0003-0078-993X; Neris,
   Romulo/0000-0002-7436-1680; da Silva Frost, Paula/0000-0002-3814-999X;
   Freitas, Leandro/0000-0002-0249-2948; Figueiredo,
   Claudia/0000-0001-9467-9891
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Institutos
   Nacionais de Pesquisa-Instituto Nacional de Neurociencia Translacional;
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Institutos
   Nacionais de Pesquisa-Inovacao em Medicamentos e Identificacao de Novos
   Alvos Terapeuticos; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES; Financiadora de Estudos e ProjetosCiencia Tecnologia e
   Inovacao (FINEP)
FX Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (to F.G.D.F.,
   S.T.F., A.T.D.P., I.A.-M., C.P.F., and J.R.C.), Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (to E.A.C.), Institutos Nacionais de
   Pesquisa-Instituto Nacional de Neurociencia Translacional (to F.G.D.F.,
   E.A.C., and S.T.F.), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (to P.S.F., G.N., F.G.D.F., E.A.C., S.T.F., A.T.D.P.,
   C.P.F., I.A.-M., and J.R.C.), Institutos Nacionais de Pesquisa-Inovacao
   em Medicamentos e Identificacao de Novos Alvos Terapeuticos (to C.P.F.),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (to
   I.N.O.S., J.V.F., L.F., and D.J.L.L.P.), and Financiadora de Estudos e
   Projetos (to A.T.D.P.).
CR Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Assuncao-Miranda I, 2016, J APPL MICROBIOL, V120, P790, DOI 10.1111/jam.13038
   Balosso S, 2013, EXP NEUROL, V247, P267, DOI 10.1016/j.expneurol.2013.05.010
   Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Dalman C, 2008, AM J PSYCHIAT, V165, P59, DOI 10.1176/appi.ajp.2007.07050740
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Edwards MJJ, 2002, NEUROLOGY, V59, P1447, DOI 10.1212/WNL.59.9.1447
   Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Ho YH, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0157-8
   Jiang PF, 2012, BRAIN RES, V1459, P1, DOI 10.1016/j.brainres.2012.03.058
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kirkman NJ, 2010, EPILEPSIA, V51, P454, DOI 10.1111/j.1528-1167.2009.02390.x
   KOVAC S, 2016, REACT OXYGEN SPECIES, V1, P38, DOI DOI 10.20455/ROS.2016.807
   Kramer AH, 2008, CURR TREAT OPTION NE, V10, P201, DOI 10.1007/s11940-008-0022-0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Libbey JE, 2008, EPILEPSIA, V49, P1066, DOI 10.1111/j.1528-1167.2008.01535.x
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Pauletti A, 2017, BRAIN, V140, P1885, DOI 10.1093/brain/awx117
   RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Smith R, 2006, PEDIATRICS, V117, P851, DOI 10.1542/peds.2005-0804
   Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Zhao K, 2010, BIOSCIENCE REP, V30, P233, DOI 10.1042/BSR20090048
NR 51
TC 32
Z9 32
U1 1
U2 15
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD JUN 6
PY 2018
VL 10
IS 444
AR eaar2749
DI 10.1126/scitranslmed.aar2749
PG 10
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA GI5IG
UT WOS:000434403600003
PM 29875203
OA Bronze
DA 2020-12-01
ER

PT J
AU Barboza, RS
   Valente, LMM
   Wolff, T
   Assuncao-Miranda, I
   Neris, RLS
   Guimaraes-Andrade, IP
   Gomes, M
AF Barboza, Rodolfo S.
   Valente, Ligia M. M.
   Wolff, Thiago
   Assuncao-Miranda, Iranaia
   Neris, Romulo L. S.
   Guimaraes-Andrade, Iris P.
   Gomes, Mario
TI Antiviral Activity of Faramea hyacinthina and Faramea truncata Leaves on
   Dengue Virus Type-2 and Their Major Compounds
SO CHEMISTRY & BIODIVERSITY
LA English
DT Article
DE Faramea hyacinthina; Faramea truncata; Rubiaceae; anti-dengue activity;
   SPE
ID UNCARIA-TOMENTOSA; FEVER
AB The defatted fractions of the Faramea hyacinthina and F.truncata (Rubiaceae) leaf MeOH extracts showed invitro non-cytotoxic and anti-dengue virus serotype 2 (DENV2) activity in human hepatocarcinoma cell lineage (HepG2). Submitting these fractions to the developed RP-SPE method allowed isolating the antiviral flavanone (2S)-isosakuranetin-7-O--d-apiofuranosyl-(16)--d-glucopyranoside (1) from both species and yielded less active sub-fractions. The new diastereoisomeric epimer pair (2S)+(2R) of 5,3,5-trihydroxyflavanone-7-O--d-apiofuranosyl-(16)--d-glucopyranoside (2a/2b) from F.hyacinthina; the known narigenin-7-O--d-apiofuranosyl-(16)--d-glucopyranoside (3) from both species; rutin (4) and quercetin-4--d-O-glucopyranosyl-3-O-rutinoside (5) from F.hyacinthina, and kaempferol-3-O-rutinoside (6), erythroxyloside A (7) and asperuloside (8) from F.truncata have been isolated from these sub-fractions. Compounds 4-8 are reported for the first time in Faramea spp.
C1 [Barboza, Rodolfo S.; Valente, Ligia M. M.; Wolff, Thiago] Univ Fed Rio de Janeiro, Inst Quim, Ctr Tecnol, Ave Athos da Silveira Ramos 149,Bl A, BR-21941909 Rio De Janeiro, RJ, Brazil.
   [Assuncao-Miranda, Iranaia; Neris, Romulo L. S.; Guimaraes-Andrade, Iris P.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Ctr Ciencias Saude, Ave Carlos Chagas Filho 373,Bl 1, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Gomes, Mario] Inst Pesquisas Jardim Bot Rio de Janeiro, R Jardim Bot 1008, BR-22470180 Rio De Janeiro, RJ, Brazil.
RP Valente, LMM (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, Ctr Tecnol, Ave Athos da Silveira Ramos 149,Bl A, BR-21941909 Rio De Janeiro, RJ, Brazil.; Assuncao-Miranda, I (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Ctr Ciencias Saude, Ave Carlos Chagas Filho 373,Bl 1, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM valente@iq.ufrj.br; iranaiamiranda@micro.ufrj.br
RI Barboza, Rodolfo/AAR-3950-2020; Valente, Ligia M M/F-3405-2014
OI Barboza, Rodolfo/0000-0002-7098-2447; Valente, Ligia M
   M/0000-0003-3195-8927
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ) [E-26/111.373/2014]; CAPESCAPES
FX This work was supported by Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ), Process No.
   E-26/111.373/2014. T. W. thanks CAPES for fellowship. The authors thank
   the NMR and MS Labs of the Instituto de Pesquisas em Produtos Naturais,
   Universidade Federal do Rio de Janeiro for the NMR and HR-MS spectra.
CR Assuncao-Miranda I, 2016, J APPL MICROBIOL, V120, P790, DOI 10.1111/jam.13038
   Barboza RS, 2015, J LIQ CHROMATOGR R T, V38, P532, DOI 10.1080/10826076.2014.917666
   FERRARI F, 1985, PHYTOCHEMISTRY, V24, P2753, DOI 10.1016/S0031-9422(00)80719-0
   Gomes Mario, 2003, Acta Bot. Bras., V17, P449, DOI 10.1590/S0102-33062003000300011
   Jaramillo K, 2011, J AGR FOOD CHEM, V59, P975, DOI 10.1021/jf103151n
   Jardim JG, 2008, NOVON, V18, P67, DOI 10.3417/2006182
   Kanchanapoom T., 2015, CHEM PHARM BULL, V53, P579
   Kazuma K, 2003, PHYTOCHEMISTRY, V62, P229, DOI 10.1016/S0031-9422(02)00486-7
   Lee LK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001676
   Lima RS, 2013, NAT PROD COMMUN, V8, P1547
   de Moura VM, 2006, QUIM NOVA, V29, P452, DOI 10.1590/S0100-40422006000300009
   Mello CD, 2017, MEM I OSWALDO CRUZ, V112, P458, DOI 10.1590/0074-02760160323
   Nascimento AC, 2017, PHYTOCHEM LETT, V19, P220, DOI 10.1016/j.phytol.2017.01.013
   Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055
   Parkash O, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-43
   Poole CF, 2003, TRAC-TREND ANAL CHEM, V22, P362, DOI 10.1016/S0165-9936(03)00605-8
   Reis SRIN, 2008, INT IMMUNOPHARMACOL, V8, P468, DOI 10.1016/j.intimp.2007.11.010
   Ribeiro AF, 2003, CBO 013 ESTACAO CIEN
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Saude S de V em M da, 2017, B EPIDEMIOLOGICO, V48, P1
   SAUVAIN M, 1994, J NAT PROD, V57, P403, DOI 10.1021/np50105a014
   Simpson N. J. K., 2000, SOLID PHASE EXTRACTI
   Suksanpaisan L, 2007, J MED VIROL, V79, P300, DOI 10.1002/jmv.20798
   Wagner H, 1996, PLANT DRUG ANAL THIN
   Wei XH, 2013, MOLECULES, V18, P1325, DOI 10.3390/molecules18011325
NR 25
TC 5
Z9 5
U1 0
U2 2
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1612-1872
EI 1612-1880
J9 CHEM BIODIVERS
JI Chem. Biodivers.
PD FEB
PY 2018
VL 15
IS 2
AR e1700393
DI 10.1002/cbdv.201700393
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA FX4PE
UT WOS:000426059500002
PM 29278459
DA 2020-12-01
ER

PT J
AU Coelho, SVA
   Neris, RLS
   Papa, MP
   Schnellrath, LC
   Meuren, LM
   Tschoeke, DA
   Leomil, L
   Vercoza, BRF
   Miranda, M
   Thompson, FL
   Da Poian, AT
   Souza, TML
   Carneiro, FA
   Damaso, CR
   Assuncao-Miranda, I
   de Arruda, LB
AF Antunes Coelho, Sharton Vinicius
   Silva Neris, Romulo Leao
   Papa, Michelle Premazzi
   Schnellrath, Laila Castro
   Meuren, Lana Monteiro
   Tschoeke, Diogo A.
   Leomil, Luciana
   Farias Vercoza, Brunno Renato
   Miranda, Milene
   Thompson, Fabiano L.
   Da Poian, Andrea Thompson
   Souza, Thiago Moreno L.
   Carneiro, Fabiana Avila
   Damaso, Clarissa R.
   Assuncao-Miranda, Iranaia
   de Arruda, Luciana Barros
TI Development of standard methods for Zika virus propagation, titration,
   and purification
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Zika virus; Virus propagation; Virus purification; Standard protocols
ID SEXUAL TRANSMISSION; BRAZIL
AB The emergence of Zika virus (ZIKV) infection has stimulated several research groups to study and collaborate to understand virus biology and pathogenesis. These efforts may assist with the development of antiviral drugs, vaccines and diagnostic tests, as well as to promote advancements in public health policies. Here, we aim to develop standard protocols for propagation, titration, and purification of ZIKV strains, by systematically testing different cell types, kinetics, multiplicity of infection and centrifugation protocols. ZIKV produces a productive infection in human, non-human primate, and rodents-derived cell lines, with different efficacies. The highest yield of ZIKV-AFR and ZIKV-BR infectious progeny was obtained at 7 days post infection in C6/36 cells (7 x 10(7) and 2 x 10(8) PFU/ml, respectively). However, high titers of ZIKV-AFR could be obtained at earlier time points in Vero cells (2.5 x 10(7) PFU/ml at 72 hpi), whereas ZIKV-BR titers reached 108 PFU/ml at 4dpi in C6/36 cells. High yield of purified virus was obtained by purification through a discontinuous sucrose gradient. This optimized procedure will certainly contribute to future studies of virus structure and vaccine development. Beyond the achievement of efficient virus propagation, the normalization of these protocols will also allow different laboratories around the world to better compare and discuss data regarding different features of ZIKV biology and disease, contributing to more efficient collaborations and progression in ZIKV research.
C1 [Antunes Coelho, Sharton Vinicius; Silva Neris, Romulo Leao; Papa, Michelle Premazzi; Meuren, Lana Monteiro; Assuncao-Miranda, Iranaia; de Arruda, Luciana Barros] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio de Janeiro, RJ, Brazil.
   [Schnellrath, Laila Castro; Damaso, Clarissa R.] Univ Fed Rio de Janeiro, IBCCF, Rio de Janeiro, RJ, Brazil.
   [Tschoeke, Diogo A.; Leomil, Luciana; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio de Janeiro, RJ, Brazil.
   [Farias Vercoza, Brunno Renato; Carneiro, Fabiana Avila] UFRJ, Polo Avancado Xerem, NUMPEX Nucleo Multidisciplinar Pesquisas, Duque De Caxias, RJ, Brazil.
   [Miranda, Milene; Souza, Thiago Moreno L.] Fundacao Oswaldo Cruz, FIOCRUZ, IOC, Lab Imunofarmacol, Rio De Janeiro, RJ, Brazil.
   [Da Poian, Andrea Thompson] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio de Janeiro, RJ, Brazil.
   [Souza, Thiago Moreno L.] Fiocruz MS, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Rio De Janeiro, RJ, Brazil.
RP Assuncao-Miranda, I; de Arruda, LB (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, CCS, Bloco 1,Lab 1-SS-048,Lab 1-SS-055, Rio De Janeiro, RJ, Brazil.
EM iranaiamiranda@micro.ufrj.br; arruda@micro.ufrj.br
RI Souza, Thiago Moreno L./G-2900-2012; Arruda, Luciana B/N-9086-2013;
   CARNEIRO, FABIANA A/S-4525-2018; Da Poian, Andrea T./V-1699-2019;
   Damaso, Clarissa R/F-7737-2012; Vercoza, Brunno Renato
   Farias/AAB-4725-2019; Tschoeke, Diogo A/F-9913-2019; Leomil,
   Luciana/O-4860-2019
OI Souza, Thiago Moreno L./0000-0003-2212-3899; Damaso, Clarissa
   R/0000-0001-6299-2816; Vercoza, Brunno Renato
   Farias/0000-0001-6117-7879; Tschoeke, Diogo A/0000-0001-8134-4259;
   Carneiro, Fabiana/0000-0002-6584-4875; Da Poian,
   Andrea/0000-0002-3969-704X; Thompson, Fabiano/0000-0002-7562-1683
FU CAPESCAPES; CAPES/PVE-Program; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPERJ-Rede ZIKA; FINEPCiencia
   Tecnologia e Inovacao (FINEP); FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by CAPES, CAPES/PVE-Program, CNPq, FAPERJ-Rede
   ZIKA, and FINEP. SVAC was the recipient of a FAPERJ fellowship. RLSN and
   MPP were recipients of CNPq fellowships. LCS was the recipient of a
   CAPES fellowship. CD and ATP are recipients of CNPq research
   fellowships.
CR Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chen SX, 2004, VIROLOGY, V318, P123, DOI 10.1016/j.virol.2003.09.013
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Freshney R. I., 2005, CULTURE ANIMAL CELLS, P315
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Maramorosch K., 1994, ARTHROPOD CELL CULTU
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nikolskaia OV, 2006, J CLIN INVEST, V116, P2739, DOI [10.1172/JCI27798., 10.1172/JC127798]
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 39
TC 25
Z9 25
U1 2
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD AUG
PY 2017
VL 246
BP 65
EP 74
DI 10.1016/j.jviromet.2017.04.011
PG 10
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA EY1PJ
UT WOS:000403737500011
PM 28445704
DA 2020-12-01
ER

PT J
AU Cruz-Oliveira, C
   Almeida, AF
   Freire, JM
   Caruso, MB
   Morando, MA
   Ferreira, VNS
   Assuncao-Miranda, I
   Gomes, AMO
   Castanho, MARB
   Da Poian, AT
AF Cruz-Oliveira, Christine
   Almeida, Andreza F.
   Freire, Joao M.
   Caruso, Marjolly B.
   Morando, Maria A.
   Ferreira, Vivian N. S.
   Assuncao-Miranda, Iranaia
   Gomes, Andre M. O.
   Castanho, Miguel A. R. B.
   Da Poian, Andrea T.
TI Mechanisms of Vesicular Stomatitis Virus Inactivation by Protoporphyrin
   IX, Zinc-Protoporphyrin IX, and Mesoporphyrin IX
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE photoactivation; porphyrin; singlet oxygen; vesicular stomatitis virus;
   viral inactivation
ID ALUMINUM PHTHALOCYANINE DERIVATIVES; HUMAN-IMMUNODEFICIENCY-VIRUS;
   PHOTODYNAMIC THERAPY; REVERSE-TRANSCRIPTASE; SINGLET OXYGEN; PORPHYRINS;
   PROTEINS; PHOTOSENSITIZERS; INHIBITION; BLOOD
AB Virus resistance to antiviral therapies is an increasing concern that makes the development of broad-spectrum antiviral drugs urgent. Targeting of the viral envelope, a component shared by a large number of viruses, emerges as a promising strategy to overcome this problem. Natural and synthetic porphyrins are good candidates for antiviral development due to their relative hydrophobicity and pro-oxidant character. In the present work, we characterized the antiviral activities of protoprophyrin IX (PPIX), Zn-protoporphyrin IX (ZnPPIX), and mesoporphyrin IX (MPIX) against vesicular stomatitis virus (VSV) and evaluated the mechanisms involved in this activity. Treatment of VSV with PPIX, ZnPPIX, and MPIX promoted dose-dependent virus inactivation, which was potentiated by porphyrin photoactivation. All three porphyrins inserted into lipid vesicles and disturbed the viral membrane organization. In addition, the porphyrins also affected viral proteins, inducing VSV glycoprotein cross-linking, which was enhanced by porphyrin photoactivation. Virus incubation with sodium azide and alpha-tocopherol partially protected VSV from inactivation by porphyrins, suggesting that singlet oxygen (O-1(2)) was the main reactive oxygen species produced by photoactivation of these molecules. Furthermore, O-1(2) was detected by 9,10-dimethylanthracene oxidation in photoactivated porphyrin samples, reinforcing this hypothesis. These results reveal the potential therapeutic application of PPIX, ZnPPIX, and MPIX as good models for broad antiviral drug design.
C1 [Cruz-Oliveira, Christine; Almeida, Andreza F.; Caruso, Marjolly B.; Ferreira, Vivian N. S.; Gomes, Andre M. O.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, Brazil.
   [Freire, Joao M.; Castanho, Miguel A. R. B.] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal.
   [Morando, Maria A.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonan Magnet Nucl, Rio De Janeiro, Brazil.
   [Morando, Maria A.] Fiocruz MS, Ctr Desenvolvimento Tecnol Saude, Rio De Janeiro, Brazil.
   [Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil.
   [Freire, Joao M.] Inst Pasteur, Unite Virol Struct, Dept Virol, Paris, France.
RP Cruz-Oliveira, C; Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, Brazil.
EM ccruz@bioqmed.ufrj.br; dapoian@bioqmed.ufrj.br
RI Da Poian, Andrea T./V-1699-2019; Gomes, Andre/C-4009-2014; Miguel
   Freire, Joao/J-4881-2015
OI FCCN, Bogus/0000-0003-1034-3552; Gomes, Andre/0000-0003-1052-8004; FCCN,
   Bogus/0000-0001-6282-8004; Castanho, Miguel/0000-0001-7891-7562; Miguel
   Freire, Joao/0000-0002-8674-0813; Cruz-Oliveira,
   Christine/0000-0003-4838-0703; Da Poian, Andrea/0000-0002-3969-704X
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ; Brazil)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/201.167/2014];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq;
   Brazil)National Council for Scientific and Technological Development
   (CNPq) [306669/2013-7]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES; Brazil)CAPES [CsF 171/2012]; Fundacao para a
   Ciencia e Tecnologia-Ministerio da Educacao e Ciencia (FCT-MEC;
   Portugal) [HIVERA/ 0002/2013]; Marie Sklodowska-Curie Actions (MSCA;
   European Commission) [INPACT 644167]; Science without Borders
   postdoctoral fellowship from CAPES [171/2012]; FCT-MEC Ph.D. fellowship
   [SFRH/BD/70423/2010]
FX This work was supported by the Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ; Brazil; grant number
   E-26/201.167/2014), the Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq; Brazil; grant number 306669/2013-7), the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES;
   Brazil; grant number CsF 171/2012), the Fundacao para a Ciencia e
   Tecnologia-Ministerio da Educacao e Ciencia (FCT-MEC; Portugal; project
   HIVERA/ 0002/2013), and Marie Sklodowska-Curie Actions (MSCA; European
   Commission project INPACT 644167). C.C.-O. acknowledges a Science
   without Borders postdoctoral fellowship from CAPES (171/2012), and
   J.M.F. acknowledges an FCT-MEC Ph.D. fellowship (SFRH/BD/70423/2010).
CR ABE H, 1995, PHOTOCHEM PHOTOBIOL, V61, P402, DOI 10.1111/j.1751-1097.1995.tb08630.x
   Abrahamse H, 2016, BIOCHEM J, V473, P347, DOI 10.1042/BJ20150942
   AFT RL, 1983, J BIOL CHEM, V258, P2069
   AFT RL, 1984, J BIOL CHEM, V259, P301
   Albertini AAV, 2012, VIRUSES-BASEL, V4, P117, DOI 10.3390/v4010117
   Assuncao-Miranda I, 2016, J APPL MICROBIOL, V120, P790, DOI 10.1111/jam.13038
   Auwarter W, 2015, NAT CHEM, V7, P105, DOI 10.1038/nchem.2159
   Beilstein F, 2015, J VIROL, V89, P11019, DOI 10.1128/JVI.01753-15
   Benati FJ, 2009, LETT APPL MICROBIOL, V49, P791, DOI 10.1111/j.1472-765X.2009.02744.x
   Benov L, 2015, MED PRIN PRACT, V24, P14, DOI 10.1159/000362416
   Carneiro FA, 2003, J BIOL CHEM, V278, P13789, DOI 10.1074/jbc.M210615200
   Casteel MJ, 2004, PHOTOCHEM PHOTOBIOL, V80, P294, DOI 10.1562/2004-04-05-RA-134.1
   Chen-Collins ARM, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-9
   Cheng Y, 2010, ANTIMICROB AGENTS CH, V54, P197, DOI 10.1128/AAC.01206-09
   Costa L, 2012, VIRUSES-BASEL, V4, P1034, DOI 10.3390/v4071034
   Craig RA, 2015, EXPERT OPIN DRUG DEL, V12, P85, DOI 10.1517/17425247.2015.962512
   Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9
   Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c
   Dixon DW, 2005, J INORG BIOCHEM, V99, P813, DOI 10.1016/j.jinorgbio.2004.12.013
   Guo HT, 2011, ANTIMICROB AGENTS CH, V55, P478, DOI 10.1128/AAC.00989-10
   Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a
   HOROWITZ B, 1991, TRANSFUSION, V31, P102, DOI 10.1046/j.1537-2995.1991.31291142938.x
   Huang Z, 2005, TECHNOL CANCER RES T, V4, P283, DOI 10.1177/153303460500400308
   Kennedy J C, 1996, J Clin Laser Med Surg, V14, P289
   KENNEDY JC, 1990, J PHOTOCH PHOTOBIO B, V6, P143, DOI 10.1016/1011-1344(90)85083-9
   LEVERE RD, 1991, P NATL ACAD SCI USA, V88, P1756, DOI 10.1073/pnas.88.5.1756
   Lim DS, 2002, J PHOTOCH PHOTOBIO B, V67, P149, DOI 10.1016/S1011-1344(02)00318-4
   Lin L, 2008, J VIROL, V82, P2305, DOI 10.1128/JVI.02147-07
   MargolisNunno H, 1996, TRANSFUSION, V36, P743, DOI 10.1046/j.1537-2995.1996.36896374381.x
   MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0
   Mead DG, 2000, SCIENCE, V287, P485, DOI 10.1126/science.287.5452.485
   Moor ACE, 1999, PHOTOCHEM PHOTOBIOL, V69, P353, DOI 10.1562/0031-8655(1999)069<0353:IOVSIT>2.3.CO;2
   Moor ACE, 1999, EUR J HAEMATOL, V62, P1
   NORTH J, 1993, J PHOTOCH PHOTOBIO B, V17, P99, DOI 10.1016/1011-1344(93)80002-Q
   PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0
   RYWKIN S, 1992, PHOTOCHEM PHOTOBIOL, V56, P463, DOI 10.1111/j.1751-1097.1992.tb02189.x
   RYWKIN S, 1994, PHOTOCHEM PHOTOBIOL, V60, P165, DOI 10.1111/j.1751-1097.1994.tb05085.x
   Santos NC, 2003, BBA-BIOMEMBRANES, V1612, P123, DOI 10.1016/S0005-2736(03)00112-3
   Schmidt-Erfurth U, 2000, SURV OPHTHALMOL, V45, P195, DOI 10.1016/S0039-6257(00)00158-2
   SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566
   Smetana Z, 1998, J PHOTOCH PHOTOBIO B, V44, P77, DOI 10.1016/S1011-1344(98)00124-9
   Smetana Z, 1997, LASER SURG MED, V21, P351, DOI 10.1002/(SICI)1096-9101(1997)21:4<351::AID-LSM6>3.0.CO;2-P
   SMETANA Z, 1994, J PHOTOCH PHOTOBIO B, V22, P37, DOI 10.1016/1011-1344(93)06949-4
   Song JM, 2010, EXPERT REV ANTI-INFE, V8, P635, DOI [10.1586/eri.10.51, 10.1586/ERI.10.51]
   Staudinger R, 1996, P ASSOC AM PHYSICIAN, V108, P47
   Stojiljkovic I, 2001, EXPERT OPIN INV DRUG, V10, P309, DOI 10.1517/13543784.10.2.309
   SZOKA F, 1980, BIOCHIM BIOPHYS ACTA, V601, P559, DOI 10.1016/0005-2736(80)90558-1
   TAPPEL AL, 1953, ARCH BIOCHEM BIOPHYS, V44, P378, DOI 10.1016/0003-9861(53)90056-3
   Trannoy LL, 2006, VOX SANG, V91, P111, DOI 10.1111/j.1423-0410.2006.00791.x
   Trannoy LL, 2004, TRANSFUSION, V44, P1186, DOI 10.1111/j.1537-2995.2004.03275.x
   Vigant F, 2010, CHEM BIOL, V17, P1049, DOI 10.1016/j.chembiol.2010.10.002
   VINCENT SH, 1988, ARCH BIOCHEM BIOPHYS, V265, P539, DOI 10.1016/0003-9861(88)90159-2
   Vzorov AN, 2002, ANTIMICROB AGENTS CH, V46, P3917, DOI 10.1128/AAC.46.12.3917-3925.2002
   Wainwright M, 2002, CURR MED CHEM, V9, P127, DOI 10.2174/0929867023371355
   Wen WH, 2009, J MED CHEM, V52, P4903, DOI 10.1021/jm900515g
NR 55
TC 7
Z9 7
U1 7
U2 18
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD JUN
PY 2017
VL 61
IS 6
AR e00053-17
DI 10.1128/AAC.00053-17
PG 14
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA EY2FH
UT WOS:000403783400016
PM 28348154
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Nascimento, AC
   Valente, LMM
   Gomes, M
   Barboza, RS
   Wolff, T
   Neris, RLS
   Figueiredo, CM
   Assuncao-Miranda, I
AF Nascimento, Adriana C.
   Valente, Ligia M. M.
   Gomes, Mario
   Barboza, Rodolfo S.
   Wolff, Thiago
   Neris, Romulo L. S.
   Figueiredo, Camila M.
   Assuncao-Miranda, Iranaia
TI Antiviral activity of Faramea bahiensis leaves on dengue virus type-2
   and characterization of a new antiviral flavanone glycoside
SO PHYTOCHEMISTRY LETTERS
LA English
DT Article
DE Faramea bahiensis; Rubiaceae Flavanone; Anti-dengue; Antiviral; Dengue
   virus
ID UNCARIA-TOMENTOSA; SEVERITY; FEVER
AB Dengue virus infection is a neglected disease prevalent in most tropical and subtropical areas. Currently there is no any antiviral drug indicated for the routine treatment of dengue patients. As part of our ongoing search for potential anti-dengue virus agents we have investigated the methanol extract of Faramea bahiensis (Rubiaceae) leaves. This species is endemic in Brazil, and there are no reports on its chemical composition or therapeutic potential. Its crude MeOH extract showed in vitro non-cytotoxicity and anti-dengue virus serotype 2 (DENV-2) activity in human hepatocarcinoma cell lineage (HepG2). A marked reduction on viral load (100%) was observed. Sequential fractionation of the bioactive crude extract led to the isolation of a bioactive new flavanone glycoside: 5-hydroxy-40-methoxy-flavanone-7O-beta-D-apiofuranosyl-(1 -> 6)-beta-D-glucopyranoside, the known 5,40-dihydroxy-flavanone-7-O-beta-D-apiofuranosyl-( 1 -> 6)-beta-D-glucopyranoside and a diateroisomeric epimer pair of the known 5,30,50trihydroxy- flavanone-7-O-beta-D-glucopyranoside. The treatment of DENV-2 infected HepG2 cells with the new flavanone was able to control viral replication promoting a reduction of the number of infected cells (12%), together with a decrease of infectious particles in the culture supernatant (97%) and of the number of RNA copies of DENV-2 in HepG2 cells (67%). Structural determinations were made by NMR techniques in one and two dimensions (H-1 NMR, C-13 NMR, COSY, HSQC and HMBC), HRMS, UV, OR and CD. (C) 2017 Phytochemical Society of Europe. Published by Elsevier Ltd. All rights reserved.
C1 [Nascimento, Adriana C.; Valente, Ligia M. M.; Barboza, Rodolfo S.; Wolff, Thiago] Univ Fed Rio de Janeiro, Inst Quimica, Av Athos Silveira Ramos 149, BR-21941 Rio De Janeiro, Brazil.
   [Nascimento, Adriana C.; Valente, Ligia M. M.; Barboza, Rodolfo S.; Wolff, Thiago] Cidade Univ, Centro Tecnologia Bl A, Rio De Janeiro, RJ, Brazil.
   [Gomes, Mario] Inst Pesquisas Jardim Botanico Rio Janeiro, R Jardim Botanico 1008, BR-22470180 Rio De Janeiro, RJ, Brazil.
   [Neris, Romulo L. S.; Figueiredo, Camila M.; Assuncao-Miranda, Iranaia] Univ Fed Rio Janeiro, Inst Microbiol Paulo Goes, Av Carlos Chagas Filho 373, BR-21941 Rio De Janeiro, Brazil.
   [Neris, Romulo L. S.; Figueiredo, Camila M.; Assuncao-Miranda, Iranaia] Cidade Univ, Ctr Ciancias Saude Bl I, BR-21941970 Rio De Janeiro, RJ, Brazil.
RP Valente, LMM (corresponding author), Univ Fed Rio de Janeiro, Inst Quimica, Av Athos Silveira Ramos 149, BR-21941 Rio De Janeiro, Brazil.; Valente, LMM (corresponding author), Cidade Univ, Centro Tecnologia Bl A, Rio De Janeiro, RJ, Brazil.; Assuncao-Miranda, I (corresponding author), Univ Fed Rio Janeiro, Inst Microbiol Paulo Goes, Av Carlos Chagas Filho 373, BR-21941 Rio De Janeiro, Brazil.; Assuncao-Miranda, I (corresponding author), Cidade Univ, Ctr Ciancias Saude Bl I, BR-21941970 Rio De Janeiro, RJ, Brazil.
EM valente@iq.ufrj.br; iranaiamiranda@micro.ufrj.br
RI Valente, Ligia M M/F-3405-2014; Barboza, Rodolfo/AAR-3950-2020
OI Valente, Ligia M M/0000-0003-3195-8927; Barboza,
   Rodolfo/0000-0002-7098-2447
FU FAPERJ- BrazilCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ) [E-26/111.373/2014];
   CNPq-BrazilNational Council for Scientific and Technological Development
   (CNPq); CAPES-BrazilCAPES
FX The authors thank the NMR Labs of the Instituto de Tecnologia em
   Farmacos - Fundacao Oswaldo Cruz/RJ and of the Instituto de Pesquisa em
   Produtos Naturais, Universidade Federal do Rio de Janeiro for the NMR
   spectra, the MS Lab of the Instituto de Pesquisa em Produtos Naturais
   for the HRESIMS and FAPERJ- Brazil for grant support (Proc. No
   E-26/111.373/2014). A.C.N. thanks CNPq-Brazil and T.W. CAPES-Brazil for
   fellowships.
CR Assuncao-Miranda I, 2016, J APPL MICROBIOL, V120, P790, DOI 10.1111/jam.13038
   Brazilian-Health-Ministry, 2016, B EPIDEMIOLOGICO, V47, P1
   Chen XQ, 2009, NAT PROD RES, V23, P442, DOI 10.1080/14786410802044885
   FERRARI F, 1985, PHYTOCHEMISTRY, V24, P2753, DOI 10.1016/S0031-9422(00)80719-0
   Funari CS, 2011, PHYTOCHEMISTRY, V72, P2052, DOI 10.1016/j.phytochem.2011.07.004
   GAFFIELD W, 1975, BIOORG CHEM, V4, P259, DOI 10.1016/0045-2068(75)90036-X
   GAFFIELD W, 1970, TETRAHEDRON, V26, P4093, DOI 10.1016/S0040-4020(01)93050-9
   Hashmi MA, 2014, SPECTROCHIM ACTA A, V128, P225, DOI 10.1016/j.saa.2014.02.163
   Khan MK, 2014, J FOOD COMPOS ANAL, V33, P85, DOI 10.1016/j.jfca.2013.11.004
   Lee LK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001676
   Lima RS, 2013, NAT PROD COMMUN, V8, P1547
   Mabry M., 1970, SYSTEMATIC IDENTIFIC
   Maltese F, 2009, FOOD CHEM, V116, P575, DOI 10.1016/j.foodchem.2009.03.023
   Masuoka C, 2003, FOOD SCI TECHNOL RES, V9, P197, DOI 10.3136/fstr.9.197
   Moco S, 2006, CHROMATOGRAPHIA, V64, P503, DOI 10.1365/s10337-006-0077-6
   Parkash O, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-43
   Reis SRIN, 2008, INT IMMUNOPHARMACOL, V8, P468, DOI 10.1016/j.intimp.2007.11.010
   Ribeiro A.F., 2003, INFLUENCIA FATORES A
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   SAUVAIN M, 1994, J NAT PROD, V57, P403, DOI 10.1021/np50105a014
   Suksanpaisan L, 2007, J MED VIROL, V79, P300, DOI 10.1002/jmv.20798
   Sun JM, 2007, CHEM PHARM BULL, V55, P474, DOI 10.1248/cpb.55.474
   Takahashi H, 2001, PHYTOCHEMISTRY, V56, P875, DOI 10.1016/S0031-9422(00)00493-3
   Wagner H, 1996, PLANT DRUG ANAL THIN
   Zhang ZZ, 2003, J NAT PROD, V66, P39, DOI 10.1021/np020429z
NR 25
TC 7
Z9 7
U1 0
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1874-3900
EI 1876-7486
J9 PHYTOCHEM LETT
JI Phytochem. Lett.
PD MAR
PY 2017
VL 19
BP 220
EP 225
DI 10.1016/j.phytol.2017.01.013
PG 6
WC Plant Sciences; Chemistry, Medicinal
SC Plant Sciences; Pharmacology & Pharmacy
GA EP5YU
UT WOS:000397455800041
DA 2020-12-01
ER

PT J
AU Reiss-Pistilli, MLV
   Schuppan, D
   Barroso, MMS
   Assuncao-Miranda, I
   Farias, S
   Lery, L
   Bauer, M
   Juliano, L
   Juliano, MA
   Coelho-Sampaio, T
AF Reiss-Pistilli, Maria L. V.
   Schuppan, Detlef
   Barroso, Madalena M. S.
   Assuncao-Miranda, Iranaia
   Farias, Shirley
   Lery, Leticia
   Bauer, Michael
   Juliano, Luiz
   Juliano, Maria A.
   Coelho-Sampaio, Tatiana
TI An extracellular proteasome releases endostatin from human collagen
   XVIII
SO ANGIOGENESIS
LA English
DT Article
DE Angiogenesis; Endostatin; Proteasome; Protease; Collagen XVIII
ID SECRETORY SPHINGOMYELINASE; CIRCULATING PROTEASOMES; GENERATION; CELLS;
   LOCALIZATION; ANGIOGENESIS; INHIBITOR; CARCINOMA; PROTEINS; REVEALS
AB Endostatin is a potent anti-angiogenic and anti-tumor protein capable of regressing tumors without inducing acquired resistance. Since it is a fragment of the parental molecule, collagen XVIII, its endogenous production depends on the activity of a specific proteolytic enzyme. While such an enzyme has been described in mice, a human counterpart has not been identified so far. Here, we searched for this enzyme by using a fluorescence resonance energy transfer peptide containing the cleavage site of human collagen XVIII. We found that the cleavage activity was present in various murine and human tumor cells but not in untransformed cells. It was ascribed to a large protein complex identified as an extracellular form of proteasome 20S. Since circulating proteasome 20S has recently emerged as an important marker of tumor progression, the possibility of proteasomes controlling the production of angiostatic endostatin may inspire the development of new anticancer therapies.
C1 [Reiss-Pistilli, Maria L. V.; Barroso, Madalena M. S.; Coelho-Sampaio, Tatiana] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.
   [Schuppan, Detlef; Bauer, Michael] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Translat Immunol, Mainz, Germany.
   [Schuppan, Detlef; Bauer, Michael] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy FZI, Mainz, Germany.
   [Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, RJ, Brazil.
   [Farias, Shirley; Juliano, Luiz; Juliano, Maria A.] Univ Fed Sao Paulo, Dept Biophys, Escola Paulista Med, Sao Paulo, SP, Brazil.
   [Lery, Leticia] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.
RP Coelho-Sampaio, T (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.
EM tcsampaio@histo.ufrj.br
OI Lery, Leticia/0000-0002-5733-8294
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [12/50191-4R];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [471340/2011-1, 470388/2010-2]
FX We thank Dr. Marilene Demasi and Dr. Claudio Masuda for helpful
   discussions and for the donation of reagents. This work was supported by
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP-Project-12/50191-4R), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq-Projects-471340/2011-1 and
   470388/2010-2).
CR Bochmann I, 2014, J CELL MOL MED, V18, P59, DOI 10.1111/jcmm.12160
   Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126
   Bohem T, 1998, BIOCHEM BIOPH RES CO, V252, P190
   Chen J, 2012, AM J NEPHROL, V35, P335, DOI 10.1159/000336109
   Claus RA, 2005, FASEB J, V19, P1719, DOI 10.1096/fj.04-2842fje
   Ding YH, 1998, P NATL ACAD SCI USA, V95, P10443, DOI 10.1073/pnas.95.18.10443
   Doehner W, 2007, EUR HEART J, V28, P821, DOI 10.1093/eurheartj/ehl541
   Dutaud D, 2002, J IMMUNOL METHODS, V260, P183, DOI 10.1016/S0022-1759(01)00555-5
   Dziankowska-Bartkowiak B, 2006, CLIN EXP RHEUMATOL, V24, P508
   Egerer K, 2002, J RHEUMATOL, V29, P2045
   Felbor U, 2000, EMBO J, V19, P1187, DOI 10.1093/emboj/19.6.1187
   Feldman AL, 2002, CANCER-AM CANCER SOC, V95, P1637, DOI 10.1002/cncr.10845
   Ferreras M, 2000, FEBS LETT, V486, P247, DOI 10.1016/S0014-5793(00)02249-3
   Fu Y, 2010, BIOCHEMISTRY-US, V49, P6420, DOI 10.1021/bi100489x
   Hasle H, 2000, Tidsskr Nor Laegeforen, V120, P2878
   Heljasvaara R, 2005, EXP CELL RES, V307, P292, DOI 10.1016/j.yexcr.2005.03.021
   Hirata I.Y., 1994, LETT PEPT SCI, V1, P299, DOI DOI 10.1007/BF00119771
   Hsieh MY, 2011, KAOHSIUNG J MED SCI, V27, P314, DOI 10.1016/j.kjms.2011.03.008
   Hu MM, 2014, BIOMED REP, V2, P898, DOI 10.3892/br.2014.319
   Iughetti P, 2001, CANCER RES, V61, P7375
   Lai Ruenn Chai, 2012, Int J Proteomics, V2012, P971907, DOI 10.1155/2012/971907
   Lavabre-Bertrand T, 2001, CANCER, V15, P2493
   Lee MC, 2000, BIOCHEM BIOPH RES CO, V279, P116, DOI 10.1006/bbrc.2000.3918
   Lin MKS, 1996, J RHEUMATOL, V23, P1162
   Marathe S, 1998, J BIOL CHEM, V273, P4081, DOI 10.1074/jbc.273.7.4081
   Morales P, 2004, MOL REPROD DEV, V68, P115, DOI 10.1002/mrd.20052
   Navon A, 2009, J BIOL CHEM, V284, P33713, DOI 10.1074/jbc.R109.018481
   OH SP, 1994, P NATL ACAD SCI USA, V91, P4229, DOI 10.1073/pnas.91.10.4229
   OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6
   REHN M, 1994, P NATL ACAD SCI USA, V91, P4234, DOI 10.1073/pnas.91.10.4234
   RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280
   Roth GA, 2005, EUR J CLIN INVEST, V35, P399, DOI 10.1111/j.1365-2362.2005.01508.x
   Saarela J, 1998, AM J PATHOL, V153, P611, DOI 10.1016/S0002-9440(10)65603-9
   Schuppan D, 1998, LANCET, V352, P879, DOI 10.1016/S0140-6736(05)60006-2
   Seppinen L, 2011, MATRIX BIOL, V30, P83, DOI 10.1016/j.matbio.2010.11.001
   Sixt SU, 2008, BBA-MOL BASIS DIS, V1782, P817, DOI 10.1016/j.bbadis.2008.06.005
   Sixt SU, 2007, AM J PHYSIOL-LUNG C, V292, pL1280, DOI 10.1152/ajplung.00140.2006
   Standker L, 1997, FEBS LETT, V420, P129, DOI 10.1016/S0014-5793(97)01503-2
   Stoebner PE, 2005, BRIT J DERMATOL, V152, P948, DOI 10.1111/j.1365-2133.2005.06487.x
   Sumi M, 2005, J CLIN LAB ANAL, V19, P146, DOI 10.1002/jcla.20069
   Sutovsky P, 2004, BIOL REPROD, V71, P1625, DOI 10.1095/biolreprod.104.032532
   Suzuki M, 2002, LUNG CANCER, V35, P29, DOI 10.1016/S0169-5002(01)00285-9
   Suzuki OT, 2002, AM J HUM GENET, V71, P1320, DOI 10.1086/344695
   Tjin RM, 2005, CANCER RES, V65, P3656, DOI 10.1158/0008-5472.CAN-04-1833
   VADAS P, 1991, IMMUNOL LETT, V28, P187, DOI 10.1016/0165-2478(91)90002-R
   VAITHILINGAM IS, 1995, J BIOL CHEM, V270, P4588, DOI 10.1074/jbc.270.9.4588
   Veillard F, 2011, J BIOL CHEM, V286, P37158, DOI 10.1074/jbc.M111.284869
   von Kruger WMA, 2006, PROTEOMICS, V6, P1495, DOI 10.1002/pmic.200500238
   WADA M, 1993, J LAB CLIN MED, V121, P215
   Wen W, 1999, CANCER RES, V59, P6052
   Wojcik C, 2000, INT J ANDROL, V23, P169
   Zhu YH, 2015, J PROTEOME RES, V14, P4319, DOI 10.1021/acs.jproteome.5b00770
   Zorick TS, 2001, EUR J HUM GENET, V9, P811, DOI 10.1038/sj.ejhg.5200721
NR 53
TC 4
Z9 5
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-6970
EI 1573-7209
J9 ANGIOGENESIS
JI Angiogenesis
PD FEB
PY 2017
VL 20
IS 1
BP 125
EP 137
DI 10.1007/s10456-016-9533-6
PG 13
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA EL2LI
UT WOS:000394450800009
PM 27921229
DA 2020-12-01
ER

PT J
AU Cavalheiro, MG
   Da Costa, LS
   Campos, HS
   Alves, LS
   Assuncao-Miranda, I
   Da Poian, AT
AF Cavalheiro, Mariana G.
   Da Costa, Leandro Silva
   Campos, Holmes S.
   Alves, Leticia S.
   Assuncao-Miranda, Iranaia
   Da Poian, Andrea T.
TI Macrophages as target cells for Mayaro virus infection: involvement of
   reactive oxygen species in the inflammatory response during virus
   replication
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE alphaviruses; Mayaro virus; macrophage activation; reactive oxygen
   species; viral arthritis
ID HUMAN-DISEASE AGENT; CHIKUNGUNYA VIRUS; MOUSE MODEL; IMMUNE-RESPONSE;
   BRAZIL; ARTHRITIS; OUTBREAK; TRAVELER; AMAZON; IDENTIFICATION
AB Alphaviruses among the viruses that cause arthritis, consisting in a public health problem worldwide by causing localized outbreaks, as well as large epidemics in humans. Interestingly, while the Old World alphaviruses are arthritogenic, the New World alphaviruses cause encephalitis. One exception is Mayaro virus (MAYV), which circulates exclusively in South America but causes arthralgia and is phylogenetically related to the Old World alphaviruses. Although MAYV-induced arthritis in humans is well documented, the molecular and cellular factors that contribute to its pathogenesis are completely unknown. In this study, we demonstrated for the first time that macrophages, key players in arthritis development, are target cells for MAYV infection, which leads to cell death through apoptosis. We showed that MAYV replication in macrophage induced the expression of TNF, a cytokine that would contribute to pathogenesis of MAYV fever, since TNF promotes an inflammatory profile characteristic of arthritis. We also found a significant increase in the production of reactive oxygen species (ROS) at early times of infection, which coincides with the peak of virus replication and precedes TNF secretion. Treatment of the cells with antioxidant agents just after infection completely abolished TNF secretion, indicating an involvement of ROS in inflammation induced during MAYV infection.
C1 [Cavalheiro, Mariana G.; Da Costa, Leandro Silva; Campos, Holmes S.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Av Carlos Chagas Filho 373,Bloco E,Sala 18, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Alves, Leticia S.; Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Av Carlos Chagas Filho 373,Bloco 1,Sala I0-55, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Av Carlos Chagas Filho 373,Bloco E,Sala 18, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM dapoian@bioqmed.ufrj.br
RI da Costa, Leandro Silva/X-9504-2019; Da Poian, Andrea T./V-1699-2019
OI da Costa, Leandro Silva/0000-0001-9697-4894; Da Poian,
   Andrea/0000-0002-3969-704X
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX The authors thank Romulo L.S. Neris for help with the experiments using
   primary macrophages. This work was supported by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).
CR ABAD-FRANCH F, 2012, PLOS NEGLECT TROP D, V6, P1169
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Assuncao-Miranda I, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/973516
   Assuncao-Miranda I, 2010, J MED VIROL, V82, P164, DOI 10.1002/jmv.21649
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Chen WQ, 2014, P NATL ACAD SCI USA, V111, P6040, DOI 10.1073/pnas.1318859111
   Chopra A, 2011, INDIAN J RHEUMATOL, V6, P5, DOI DOI 10.1016/S0973-3698(11)60023-X
   da Costa LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033871
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009
   Dhanwani R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092813
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Friedrich-Janicke B, 2014, EMERG INFECT DIS, V20, P1255, DOI 10.3201/eid2007.140043
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Mourao MPG, 2015, REV SOC BRAS MED TRO, V48, P20, DOI 10.1590/0037-8682-0133-2013
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159
   Hassing RJ, 2010, J INFECTION, V61, P343, DOI 10.1016/j.jinf.2010.06.009
   Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   HOCH AL, 1981, AM J TROP MED HYG, V30, P689, DOI 10.4269/ajtmh.1981.30.689
   Hu SX, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-123
   Joubert PE, 2012, J EXP MED, V209, P1029, DOI 10.1084/jem.20110996
   Koenderman L, 2014, IMMUNOL LETT, V162, P95, DOI 10.1016/j.imlet.2014.10.010
   Krejbich-Trotot P, 2011, FASEB J, V25, P314, DOI 10.1096/fj.10-164178
   Kumar S, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-313
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lavergne A, 2006, VIRUS RES, V117, P283, DOI 10.1016/j.virusres.2005.11.006
   Li ML, 2004, INT REV IMMUNOL, V23, P7, DOI 10.1080/08830180490265529
   Lidbury BA, 2000, J VIROL, V74, P8376, DOI 10.1128/JVI.74.18.8376-8381.2000
   Lidbury BA, 2008, J INFECT DIS, V197, P1585, DOI 10.1086/587841
   Lidbury BA, 2011, J VIROL, V85, P5651, DOI 10.1128/JVI.01189-10
   LIN KI, 1995, J CELL BIOL, V131, P1149, DOI 10.1083/jcb.131.5.1149
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Monaco C, 2015, INT IMMUNOL, V27, P55, DOI 10.1093/intimm/dxu102
   Morgan MJ, 2008, CELL RES, V18, P343, DOI 10.1038/cr.2008.31
   Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006
   Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018
   MOWATT L, 2014, J INFECT DIS THER, P1
   Ogier-Denis E, 2008, SEMIN IMMUNOPATHOL, V30, P291, DOI 10.1007/s00281-008-0120-9
   Patil DR, 2012, MICROBES INFECT, V14, P457, DOI 10.1016/j.micinf.2011.12.008
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   Pinkus R, 1996, J BIOL CHEM, V271, P13422, DOI 10.1074/jbc.271.23.13422
   Poo YS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003354
   Receveur MC, 2010, EUROSURVEILLANCE, V15, P6
   Reshi Mohammad Latif, 2014, Int J Cell Biol, V2014, P467452, DOI 10.1155/2014/467452
   Silva-Nunes Mônica da, 2006, Cad. Saúde Pública, V22, P1325, DOI 10.1590/S0102-311X2006000600021
   Slegers CAD, 2014, J CLIN VIROL, V60, P317, DOI 10.1016/j.jcv.2014.04.020
   Soucy-Faulkner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000930
   Stoermer KA, 2012, J IMMUNOL, V189, P4047, DOI 10.4049/jimmunol.1201240
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Talarmin A, 1998, AM J TROP MED HYG, V59, P452, DOI 10.4269/ajtmh.1998.59.452
   Tavares-Neto José, 2004, Rev. Soc. Bras. Med. Trop., V37, P1, DOI 10.1590/S0037-86822004000100001
   Terzian ACB, 2015, AM J TROP MED HYG, V92, P401, DOI 10.4269/ajtmh.14-0417
   Theilacker C, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-369
   Torres JR, 2004, EMERG INFECT DIS, V10, P1304
   Vejrazka M, 2005, BBA-GEN SUBJECTS, V1722, P143, DOI 10.1016/j.bbagen.2004.12.008
   Way SJR, 2002, VIROLOGY, V301, P281, DOI 10.1006/viro.2002.1587
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 62
TC 12
Z9 12
U1 0
U2 2
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PD SEP
PY 2016
VL 88
IS 3
BP 1485
EP 1499
DI 10.1590/0001-3765201620150685
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DW0OP
UT WOS:000383340200027
PM 27627069
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Assuncao-Miranda, I
   Cruz-Oliveira, C
   Neris, RLS
   Figueiredo, CM
   Pereira, LPS
   Rodrigues, D
   Araujo, DFF
   Da Poian, AT
   Bozza, MT
AF Assuncao-Miranda, I.
   Cruz-Oliveira, C.
   Neris, R. L. S.
   Figueiredo, C. M.
   Pereira, L. P. S.
   Rodrigues, D.
   Araujo, D. F. F.
   Da Poian, A. T.
   Bozza, M. T.
TI Inactivation of Dengue and Yellow Fever viruses by heme,
   cobalt-protoporphyrin IX and tin-protoporphyrin IX
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Article
DE antiviral; Dengue Virus; inactivation; metalloporphyrins; Yellow Fever
   Virus
ID CARBON-MONOXIDE; IN-VITRO; INFECTION; REPLICATION; INHIBITION;
   PORPHYRINS; PROTEIN; ENTRY; MACROPHAGES; OXYGENASE-1
AB AimsTo investigate the effect of heme, cobalt-protoporphyrin IX and tin-protoporphyrin IX (CoPPIX and SnPPIX), macrocyclic structures composed by a tetrapyrrole ring with a central metallic ion, on Dengue Virus (DENV) and Yellow Fever Virus (YFV) infection.
   Methods and ResultsTreatment of HepG2 cells with heme, CoPPIX and SnPPIX after DENV infection reduced infectious particles without affecting viral RNA contents in infected cells. The reduction of viral load occurs only with the direct contact of DENV with porphyrins, suggesting a direct effect on viral particles. Previously incubation of DENV and YFV with heme, CoPPIX and SnPPIX resulted in viral particles inactivation in a dose-dependent manner. Biliverdin, a noncyclical porphyrin, was unable to inactivate the viruses tested. Infection of HepG2 cells with porphyrin-pretreated DENV2 results in a reduced or abolished viral protein synthesis, RNA replication and cell death. Treatment of HepG2 or THP-1 cell lineage with heme or CoPPIX after DENV infection with a very low MOI resulted in a decreased DENV replication and protection from death.
   ConclusionsHeme, CoPPIX and SnPPIX possess a marked ability to inactivate DENV and YFV, impairing its ability to infect and induce cytopathic effects on target cells.
   Significance and Impact of the StudyThese results open the possibility of therapeutic application of porphyrins or their use as models to design new antiviral drugs against DENV and YFV.
C1 [Assuncao-Miranda, I.; Neris, R. L. S.; Figueiredo, C. M.; Rodrigues, D.; Araujo, D. F. F.; Bozza, M. T.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil.
   [Cruz-Oliveira, C.; Pereira, L. P. S.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, Brazil.
RP Assuncao-Miranda, I; Bozza, MT (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil.
EM iranaiamiranda@micro.ufrj.br; mbozza@micro.ufrj.br
RI Da Poian, Andrea T./V-1699-2019
OI Rodrigues, Danielle/0000-0003-2120-3352; Da Poian,
   Andrea/0000-0002-3969-704X; Cruz-Oliveira, Christine/0000-0003-4838-0703
CR Benati FJ, 2009, LETT APPL MICROBIOL, V49, P791, DOI 10.1111/j.1472-765X.2009.02744.x
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chen-Collins ARM, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-9
   Cheng Y, 2010, ANTIMICROB AGENTS CH, V54, P197, DOI 10.1128/AAC.01206-09
   Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104
   Chung SW, 2009, CELL MICROBIOL, V11, P199, DOI 10.1111/j.1462-5822.2008.01261.x
   Conceicao TM, 2010, J VIROL METHODS, V163, P1, DOI 10.1016/j.jviromet.2009.10.001
   Costa L, 2012, VIRUSES-BASEL, V4, P1034, DOI 10.3390/v4071034
   Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000
   Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668
   De La Guardia C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/825039
   Dutra FF, 2014, P NATL ACAD SCI USA, V111, pE4110, DOI 10.1073/pnas.1405023111
   Fernandez PL, 2010, J BIOL CHEM, V285, P32844, DOI 10.1074/jbc.M110.146076
   Fortes GB, 2012, BLOOD, V119, P2368, DOI 10.1182/blood-2011-08-375303
   Guo HT, 2011, ANTIMICROB AGENTS CH, V55, P478, DOI 10.1128/AAC.00989-10
   Hou WH, 2010, GASTROENTEROLOGY, V138, P1909, DOI 10.1053/j.gastro.2009.11.001
   Ichiyama K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002188
   Lawrence S P, 2000, Adv Intern Med, V45, P65
   Lee JC, 2015, ANTIVIR RES, V116, P1, DOI 10.1016/j.antiviral.2015.01.002
   Lehmann E, 2010, HEPATOLOGY, V51, P398, DOI 10.1002/hep.23339
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lin YL, 2002, ANTIVIR RES, V56, P93, DOI 10.1016/S0166-3542(02)00095-5
   Mazzola S, 2005, FASEB J, V19, P2045, DOI 10.1096/fj.05-3782fje
   Mazzucco MB, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0134-2
   Osorio JE, 2014, LANCET INFECT DIS, V14, P830, DOI 10.1016/S1473-3099(14)70811-4
   Otterbein LE, 2000, NAT MED, V6, P422
   Paiva CN, 2012, J CLIN INVEST, V122, P2531, DOI 10.1172/JCI58525
   Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   Pushpan S. K., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P187, DOI 10.2174/1568011023354137
   Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005
   Schmidt WN, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00129
   Silva EFF, 2010, CHEM-EUR J, V16, P9273, DOI 10.1002/chem.201000111
   Staudinger R, 1996, P ASSOC AM PHYSICIAN, V108, P47
   Stojiljkovic I, 2001, EXPERT OPIN INV DRUG, V10, P309, DOI 10.1517/13543784.10.2.309
   Vigant F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003297
   Vzorov AN, 2002, ANTIMICROB AGENTS CH, V46, P3917, DOI 10.1128/AAC.46.12.3917-3925.2002
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Wegiel B, 2014, ANTIOXID REDOX SIGN, V20, P1709, DOI 10.1089/ars.2013.5667
   Wen WH, 2009, J MED CHEM, V52, P4903, DOI 10.1021/jm900515g
   Wolf MC, 2010, P NATL ACAD SCI USA, V107, P3157, DOI 10.1073/pnas.0909587107
   Woodland DL, 2015, VIRAL IMMUNOL, V28, P75, DOI 10.1089/vim.2015.1502
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhu ZW, 2010, HEPATOLOGY, V52, P1897, DOI 10.1002/hep.23921
NR 45
TC 16
Z9 17
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1364-5072
EI 1365-2672
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PD MAR
PY 2016
VL 120
IS 3
BP 790
EP 804
DI 10.1111/jam.13038
PG 15
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA DF1JB
UT WOS:000371094600024
PM 26759117
OA Bronze
DA 2020-12-01
ER

PT J
AU Mietto, BS
   Jurgensen, S
   Alves, L
   Pecli, C
   Narciso, MS
   Assuncao-Miranda, I
   Villa-Verde, DMS
   Lima, FRD
   de Menezes, JRL
   Benjamim, CF
   Bozza, MT
   Martinez, AMB
AF Mietto, Bruno Siqueira
   Jurgensen, Sofia
   Alves, Lucineia
   Pecli, Cyntia
   Narciso, Marcelo Sampaio
   Assuncao-Miranda, Iranaia
   Serra Villa-Verde, Dea Maria
   de Souza Lima, Flavia Regina
   Lacerda de Menezes, Joao Ricardo
   Benjamim, Claudia Farias
   Bozza, Marcelo Torres
   Blanco Martinez, Ana Maria
TI Lack of galectin-3 speeds Wallerian degeneration by altering TLR and
   pro-inflammatory cytokine expressions in injured sciatic nerve
SO EUROPEAN JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE macrophages; mice; neuroinflammation; Schwann cells; sciatic nerve
ID MONOCYTE CHEMOATTRACTANT PROTEIN-1; TOLL-LIKE RECEPTORS;
   PERIPHERAL-NERVE; FUNCTIONAL RECOVERY; SCHWANN-CELLS; MACROPHAGE
   ACTIVATION; SIGNALING PATHWAYS; PHAGOCYTOSIS; REGENERATION;
   INTERLEUKIN-1-BETA
AB Wallerian degeneration (WD) comprises a series of events that includes activation of non-neuronal cells and recruitment of immune cells, creating an inflammatory milieu that leads to extensive nerve fragmentation and subsequent clearance of the myelin debris, both of which are necessary prerequisites for effective nerve regeneration. Previously, we documented accelerated axon regeneration in animals lacking galectin-3 (Gal-3), a molecule associated with myelin clearance. To clarify the mechanisms underlying this enhanced regeneration, we focus here on the early steps of WD following sciatic nerve crush in Gal-3/ mice. Using an in vivo model of nerve degeneration, we observed that removal of myelin debris is more efficient in Gal-3/ than in wild-type (WT) mice; we next used an in vitro phagocytosis assay to document that the phagocytic potential of macrophages and Schwann cells was enhanced in the Gal-3/ mice. Moreover, both RNA and protein levels for the pro-inflammatory cytokines IL-1 and TNF-, as well as for Toll-like receptor (TLR)-2 and -4, show robust increases in injured nerves from Gal-3/mice compared to those from WT mice. Collectively, these data indicate that the lack of Gal-3 results in an augmented inflammatory profile that involves the TLRcytokine pathway, and increases the phagocytic capacity of Schwann cells and macrophages, which ultimately contributes to speeding the course of WD.
C1 [Mietto, Bruno Siqueira; Jurgensen, Sofia; Alves, Lucineia; Narciso, Marcelo Sampaio; Blanco Martinez, Ana Maria] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Pesquisa Neurociencia Basica & Clin, Lab Neurodegeneracao & Reparo, Rio De Janeiro, RJ, Brazil.
   [Pecli, Cyntia; Benjamim, Claudia Farias] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Imunofarmacol, Rio De Janeiro, RJ, Brazil.
   [Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Lab Resposta Celular Infeccoes Virais, Rio De Janeiro, RJ, Brazil.
   [Serra Villa-Verde, Dea Maria] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisas Timo, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [de Souza Lima, Flavia Regina] Univ Fed Rio de Janeiro, Programa Biol Celular & Desenvolvimento, Lab Morfogenese Celular, Rio De Janeiro, RJ, Brazil.
   [Lacerda de Menezes, Joao Ricardo] Univ Fed Rio de Janeiro, Programa Anat, Lab Neuroanat Celular, Rio De Janeiro, RJ, Brazil.
   [Bozza, Marcelo Torres] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Lab Inflamacao & Imunidade, Rio De Janeiro, RJ, Brazil.
RP Martinez, AMB (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Pesquisa Neurociencia Basica & Clin, Lab Neurodegeneracao & Reparo, Rio De Janeiro, RJ, Brazil.
EM martinez@histo.ufrj.br
RI Martinez, Ana/C-6318-2014; Mietto, Bruno/J-1261-2016; Villa-Verde, Dea
   M.S./Q-1238-2016; Menezes, Joao R. L./D-5668-2012; Benjamim,
   Claudia/T-5090-2019
OI Mietto, Bruno/0000-0002-4172-2670; Villa-Verde, Dea
   M.S./0000-0002-2685-5512; Benjamim, Claudia/0000-0001-6247-9596; Souza
   Lima, Flavia Regina/0000-0003-0799-9235; Bozza,
   Marcelo/0000-0003-3683-7550
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX The authors declare no competing financial interests. This work was
   supported by CNPq, CAPES and FAPERJ. We are grateful to Jose Eduardo
   Goncalves dos Santos for technical assistance with the nanoliter
   microinjector.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Boivin A, 2007, J NEUROSCI, V27, P12565, DOI 10.1523/JNEUROSCI.3027-07.2007
   Bruck W, 1997, BRAIN PATHOL, V7, P741, DOI 10.1111/j.1750-3639.1997.tb01060.x
   Chattopadhyay S, 2007, BRAIN BEHAV IMMUN, V21, P561, DOI 10.1016/j.bbi.2006.10.015
   Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020
   Ferraz LC, 2008, EUR J IMMUNOL, V38, P2762, DOI 10.1002/eji.200737986
   Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195
   Filer A, 2009, ARTHRITIS RHEUM, V60, P1604, DOI 10.1002/art.24574
   Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110
   Goethals S, 2010, GLIA, V58, P1701, DOI 10.1002/glia.21041
   Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200
   Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x
   Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9
   Jeon SB, 2010, J IMMUNOL, V185, P7037, DOI 10.4049/jimmunol.1000154
   Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850
   Lee H, 2006, BIOCHEM BIOPH RES CO, V350, P742, DOI 10.1016/j.bbrc.2006.09.108
   Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LUBINSKA L, 1977, BRAIN RES, V130, P47, DOI 10.1016/0006-8993(77)90841-1
   MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650
   Martini R, 2008, GLIA, V56, P1566, DOI 10.1002/glia.20766
   MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Murakami M, 1997, CRIT REV IMMUNOL, V17, P225, DOI 10.1615/CritRevImmunol.v17.i3-4.10
   Nadeau S, 2011, J NEUROSCI, V31, P12533, DOI 10.1523/JNEUROSCI.2840-11.2011
   Narciso MS, 2009, EXP NEUROL, V217, P7, DOI 10.1016/j.expneurol.2009.01.008
   Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f
   Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001
   Oliveira JT, 2010, NEUROSCIENCE, V170, P1295, DOI 10.1016/j.neuroscience.2010.08.042
   Ousman SS, 2000, GLIA, V30, P92, DOI 10.1002/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.0.CO;2-W
   Perrin FE, 2005, BRAIN, V128, P854, DOI 10.1093/brain/awh407
   PERRY VH, 1995, EUR J NEUROSCI, V7, P271, DOI 10.1111/j.1460-9568.1995.tb01063.x
   REICHERT F, 1994, J NEUROSCI, V14, P3231
   Reichert F, 1996, J NEUROIMMUNOL, V70, P153, DOI 10.1016/S0165-5728(96)00112-9
   Rotshenker S, 2008, GLIA, V56, P1607, DOI 10.1002/glia.20713
   Rotshenker S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-109
   Ruas LP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004519
   Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592
   Shamash S, 2002, J NEUROSCI, V22, P3052, DOI 10.1523/JNEUROSCI.22-08-03052.2002
   STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086
   Subang MC, 2001, EUR J NEUROSCI, V13, P521, DOI 10.1046/j.1460-9568.2001.01425.x
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126
   Vargas ME, 2010, P NATL ACAD SCI USA, V107, P11993, DOI 10.1073/pnas.1001948107
   Winzeler AM, 2011, J NEUROSCI, V31, P6481, DOI 10.1523/JNEUROSCI.3004-10.2011
NR 44
TC 23
Z9 23
U1 2
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0953-816X
EI 1460-9568
J9 EUR J NEUROSCI
JI Eur. J. Neurosci.
PD MAY
PY 2013
VL 37
IS 10
BP 1682
EP 1690
DI 10.1111/ejn.12161
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA 148AK
UT WOS:000319213900013
PM 23406314
DA 2020-12-01
ER

PT J
AU Carvalho, FA
   Martins, IC
   Carneiro, FA
   Assuncao-Miranda, I
   Faustino, AF
   Castanho, M
   Mohana-Borges, R
   Almeida, FCL
   Da Poian, AT
   Santos, NC
AF Carvalho, Filomena A.
   Martins, Ivo C.
   Carneiro, Fabiana A.
   Assuncao-Miranda, Iranaia
   Faustino, Andre F.
   Castanho, Miguel
   Mohana-Borges, Ronaldo
   Almeida, Fabio C. L.
   Da Poian, Andrea T.
   Santos, Nuno C.
TI Dengue Virus Capsid Protein Binding to Lipid Droplets and its
   Inhibition. towards a New Drug Target
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 57th Annual Meeting of the Biophysical-Society
CY FEB 02-06, 2013
CL Philadelphia, PA
SP Biophys Soc
C1 [Carvalho, Filomena A.; Martins, Ivo C.; Faustino, Andre F.; Castanho, Miguel; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.
   [Carneiro, Fabiana A.; Assuncao-Miranda, Iranaia; Mohana-Borges, Ronaldo; Almeida, Fabio C. L.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI CARNEIRO, FABIANA A/S-4525-2018; Martins, Ivo C/G-2534-2013; Borges,
   Ronaldo S Mohana/C-5575-2013; Carvalho, Filomena A./M-9202-2013; Santos,
   Nuno/N-7248-2013
OI Martins, Ivo C/0000-0002-9284-8599; Carvalho, Filomena
   A./0000-0001-6088-3894; Santos, Nuno/0000-0002-0580-0475
CR Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
NR 2
TC 0
Z9 0
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JAN 29
PY 2013
VL 104
IS 2
SU 1
BP 415A
EP 415A
DI 10.1016/j.bpj.2012.11.2313
PG 1
WC Biophysics
SC Biophysics
GA 105MI
UT WOS:000316074304114
OA Bronze
DA 2020-12-01
ER

PT J
AU Assuncao-Miranda, I
   Cruz-Oliveira, C
   Da Poian, AT
AF Assuncao-Miranda, Iranaia
   Cruz-Oliveira, Christine
   Da Poian, Andrea T.
TI Molecular Mechanisms Involved in the Pathogenesis of Alphavirus-Induced
   Arthritis
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID ROSS-RIVER-VIRUS; MIGRATION INHIBITORY FACTOR; CALCIUM-BINDING PROTEINS;
   CHIKUNGUNYA VIRUS; SINDBIS-VIRUS; MOUSE MODEL; INFLAMMATORY RESPONSE;
   NEONATAL MICE; WILD-TYPE; EPIDEMIC POLYARTHRITIS
AB Arthritogenic alphaviruses, including Ross River virus (RRV), Chikungunya virus (CHIKV), Sindbis virus (SINV), Mayaro virus (MAYV), O'nyong-nyong virus (ONNV), and Barmah Forest virus (BFV), cause incapacitating and long lasting articular disease/myalgia. Outbreaks of viral arthritis and the global distribution of these diseases point to the emergence of arthritogenic alphaviruses as an important public health problem. This review discusses the molecular mechanisms involved in alphavirus-induced arthritis, exploring the recent data obtained with in vitro systems and in vivo studies using animal models and samples from patients. The factors associated to the extension and persistence of symptoms are highlighted, focusing on (a) virus replication in target cells, and tissues, including macrophages and muscle cells; (b) the inflammatory and immune responses with recruitment and activation of macrophage, NK cells and T lymphocytes to the lesion focus and the increase of inflammatory mediators levels; and (c) the persistence of virus or viral products in joint and muscle tissues. We also discuss the importance of the establishment of novel animal models to test new molecular targets and to develop more efficient and selective drugs to treat these diseases.
C1 [Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Prof Paulo de Goes, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Cruz-Oliveira, Christine; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med, Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM dapoian@bioqmed.ufrj.br
RI Da Poian, Andrea T./V-1699-2019
OI Cruz-Oliveira, Christine/0000-0003-4838-0703; Da Poian,
   Andrea/0000-0002-3969-704X
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).
CR Abad-Franch F., 2012, PLOS NEGLECTED TROPI, V6
   Aggarwal A, 2007, CLIN EXP IMMUNOL, V148, P515, DOI 10.1111/j.1365-2249.2007.03377.x
   Assuncao-Miranda I, 2010, J MED VIROL, V82, P164, DOI 10.1002/jmv.21649
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Bouquillard E, 2009, JOINT BONE SPINE, V76, P654, DOI 10.1016/j.jbspin.2009.08.005
   Brehin AC, 2009, VIROLOGY, V384, P216, DOI 10.1016/j.virol.2008.10.021
   BRIGHTON SW, 1983, S AFR MED J, V63, P313
   Burke CW, 2009, VIROLOGY, V395, P121, DOI 10.1016/j.virol.2009.08.039
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Chaaitanya IK, 2011, VIRAL IMMUNOL, V24, P265, DOI 10.1089/vim.2010.0123
   Chopra A, 2012, EPIDEMIOL INFECT, V140, P842, DOI 10.1017/S0950268811001300
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Cruz CC, 2010, VIROLOGY, V399, P1, DOI 10.1016/j.virol.2009.12.031
   Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446
   EATON BT, 1976, VIROLOGY, V72, P266, DOI 10.1016/0042-6822(76)90329-9
   Flexman JP, 1998, MED J AUSTRALIA, V169, P159, DOI 10.5694/j.1326-5377.1998.tb116019.x
   FRASER JRE, 1981, AUST NZ J MED, V11, P168, DOI 10.1111/j.1445-5994.1981.tb04226.x
   FRASER JRE, 1986, CLIN RHEUM DIS, V12, P369
   FRASER JRE, 1980, AUST NZ J MED, V10, P597, DOI 10.1111/j.1445-5994.1980.tb04238.x
   Gardner CL, 2012, VIROLOGY, V425, P103, DOI 10.1016/j.virol.2011.12.020
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Garmashova N, 2006, J VIROL, V80, P5686, DOI 10.1128/JVI.02739-05
   Gibney KB, 2011, CLIN INFECT DIS, V52, pE121, DOI 10.1093/cid/ciq214
   Gunn BM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002586
   Hanaoka R, 2003, ARTHRITIS RES THER, V5, pR74, DOI 10.1186/ar616
   Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001
   HAZELTON RA, 1985, AUST NZ J MED, V15, P336, DOI 10.1111/j.1445-5994.1985.tb04048.x
   Heise MT, 2000, J VIROL, V74, P9294, DOI 10.1128/JVI.74.19.9294-9299.2000
   Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181
   Herrero LJ, 2011, P NATL ACAD SCI USA, V108, P12048, DOI 10.1073/pnas.1101089108
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   INGLOT AD, 1973, J GEN VIROL, V20, P105, DOI 10.1099/0022-1317-20-1-105
   INGLOT AD, 1973, ACTA MICROBIOL POL, V5, P181
   Islam M N, 2012, Mymensingh Med J, V21, P372
   Jaffar-Bandjee MC, 2010, EXPERT REV ANTI-INFE, V8, P987, DOI [10.1586/eri.10.92, 10.1586/ERI.10.92]
   Jansen KA, 2013, MED ANTHROPOL, V32, P174, DOI 10.1080/01459740.2012.679981
   Jones PH, 2013, VIROLOGY, V438, P37, DOI 10.1016/j.virol.2013.01.010
   Kelvin AA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001279
   Kiwanuka N, 1999, CLIN INFECT DIS, V29, P1243, DOI 10.1086/313462
   Klimstra WB, 1999, J VIROL, V73, P10387, DOI 10.1128/JVI.73.12.10387-10398.1999
   Kuan WP, 2010, J RHEUMATOL, V37, P257, DOI 10.3899/jrheum.090769
   Kumar S., 2012, VIROLOGY J, V9
   Kurkela S, 2005, J INFECT DIS, V191, P1820, DOI 10.1086/430007
   Kurkela S, 2008, SCAND J INFECT DIS, V40, P167, DOI 10.1080/00365540701586996
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Laine M, 2000, RHEUMATOLOGY, V39, P1272, DOI 10.1093/rheumatology/39.11.1272
   Laine M, 2004, J INTERN MED, V256, P457, DOI 10.1111/j.1365-2796.2004.01413.x
   LaLinn M, 1996, J GEN VIROL, V77, P407, DOI 10.1099/0022-1317-77-3-407
   Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104
   Lidbury BA, 2000, J INFECT DIS, V181, P27, DOI 10.1086/315164
   Lidbury BA, 2000, J VIROL, V74, P8376, DOI 10.1128/JVI.74.18.8376-8381.2000
   Lidbury BA, 2008, J INFECT DIS, V197, P1585, DOI 10.1086/587841
   Lidbury BA, 2011, J VIROL, V85, P5651, DOI 10.1128/JVI.01189-10
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Mateo L, 2000, INTERVIROLOGY, V43, P55, DOI 10.1159/000025023
   Mavalankar D, 2007, LANCET INFECT DIS, V7, P306, DOI 10.1016/S1473-3099(07)70091-9
   Mizuno Y, 2011, J INFECT CHEMOTHER, V17, P419, DOI 10.1007/s10156-010-0124-y
   Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006
   Morrison TE, 2008, J VIROL, V82, P11263, DOI 10.1128/JVI.01352-08
   Morrison TE, 2007, J VIROL, V81, P5132, DOI 10.1128/JVI.02799-06
   Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018
   Munoz M, 2012, BIOMEDICA, V32, P286, DOI 10.1590/S0120-41572012000300017
   MURPHY FA, 1973, J INFECT DIS, V127, P129, DOI 10.1093/infdis/127.2.129
   Mylonas AD, 2004, JCR-J CLIN RHEUMATOL, V10, P326, DOI 10.1097/01.rhu.0000147052.11190.36
   Mylonas AD, 2002, MED J AUSTRALIA, V177, P356, DOI 10.5694/j.1326-5377.2002.tb04837.x
   Naish S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025688
   Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631
   Nandakumar K. S., 2006, ARTHRITIS RES THERAP, V8
   Neighbours LM, 2012, J VIROL, V86, P10675, DOI 10.1128/JVI.00601-12
   Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261
   Noret M, 2012, J INFECT DIS, V206, P455, DOI 10.1093/infdis/jis368
   ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0
   Onodera S, 2000, J BIOL CHEM, V275, P444, DOI 10.1074/jbc.275.1.444
   Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527
   Passmore Jonathon, 2002, Commun Dis Intell Q Rep, V26, P600
   Patil DR, 2012, MICROBES INFECT, V14, P457, DOI 10.1016/j.micinf.2011.12.008
   Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3
   Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12
   Rulli NE, 2011, J INFECT DIS, V204, P1026, DOI 10.1093/infdis/jir470
   Rulli NE, 2009, ARTHRITIS RHEUM-US, V60, P2513, DOI 10.1002/art.24682
   Ruschpler P, 2003, ARTHRITIS RES THER, V5, pR241, DOI 10.1186/ar783
   Ryman KD, 2000, J VIROL, V74, P3366, DOI 10.1128/JVI.74.7.3366-3378.2000
   Sane J, 2012, CLIN INFECT DIS, V55, P358, DOI 10.1093/cid/cis405
   Sane J, 2012, J INFECT DIS, V206, P407, DOI 10.1093/infdis/jis358
   Santos LL, 2009, CLIN CHIM ACTA, V399, P1, DOI 10.1016/j.cca.2008.09.014
   Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   SEAY AR, 1981, NEUROLOGY, V31, P656, DOI 10.1212/WNL.31.6.656
   Seeliger S, 2003, AM J PATHOL, V163, P947, DOI 10.1016/S0002-9440(10)63454-2
   Seymour RL, 2013, AM J TROP MED HYG, V88, P1170, DOI 10.4269/ajtmh.12-0674
   Shabman RS, 2007, J VIROL, V81, P237, DOI 10.1128/JVI.01590-06
   Shabman RS, 2008, J VIROL, V82, P12374, DOI 10.1128/JVI.00985-08
   Simmons JD, 2010, J VIROL, V84, P11429, DOI 10.1128/JVI.00577-10
   Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1
   Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389
   Soden M, 2000, ARTHRITIS RHEUM, V43, P365, DOI 10.1002/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E
   Sourisseau M., 2007, PLOS PATHOGENS, V3
   Staikowsky F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007603
   Storm N., 2013, EPIDEMIOLOGY INFECT
   Suhrbier A, 2004, CURR OPIN RHEUMATOL, V16, P374, DOI 10.1097/01.bor.0000130537.76808.26
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Suhrbier A, 2009, PHARMACOL THERAPEUT, V124, P301, DOI 10.1016/j.pharmthera.2009.09.005
   Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939
   Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120
   Teo TH, 2013, J IMMUNOL, V190, P259, DOI 10.4049/jimmunol.1202177
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   Toivanen A, 2008, CURR OPIN RHEUMATOL, V20, P486, DOI 10.1097/BOR.0b013e328303220b
   Trgovcich J, 1996, VIROLOGY, V224, P73, DOI 10.1006/viro.1996.0508
   Trgovcich J, 1999, VIROLOGY, V263, P339, DOI 10.1006/viro.1999.9913
   Trgovcich J, 1997, VIROLOGY, V227, P234, DOI 10.1006/viro.1996.8289
   Tsuboi N, 2011, ARTHRITIS RHEUM-US, V63, P467, DOI 10.1002/art.30141
   Ueno A, 2005, RHEUMATOL INT, V25, P361, DOI 10.1007/s00296-004-0449-x
   Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006
   Vijayakumar KP, 2011, J GLOB INFECT DIS, V3, P221, DOI 10.4103/0974-777X.83526
   Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   White LK, 2011, J VIROL, V85, P606, DOI 10.1128/JVI.00767-10
   Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023
NR 119
TC 46
Z9 48
U1 0
U2 11
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
VL 2013
AR 973516
DI 10.1155/2013/973516
PG 11
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 215WF
UT WOS:000324240800001
PM 24069610
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Carvalho, FA
   Carneiro, FA
   Martins, IC
   Assuncao-Miranda, I
   Faustino, AF
   Castanho, M
   Mohana-Borges, R
   Da Poian, AT
   Santos, NC
AF Carvalho, F. A.
   Carneiro, F. A.
   Martins, I. C.
   Assuncao-Miranda, I.
   Faustino, A. F.
   Castanho, M.
   Mohana-Borges, R.
   Da Poian, A. T.
   Santos, N. C.
TI AFM-based force spectroscopy probing of dengue virus capsid protein
   binding to lipid droplets-towards a new drug target
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 22nd International-Union-of-Biochemistry-and-Molecular-Biology (IUBMB)
   Congress/37th Federation-of-European-Biochemical-Societies (FEBS)
   Congress
CY SEP 04-09, 2012
CL Seville, SPAIN
SP Int Union Biochem & Mol Biol (IUBMB), Federat European Biochem Soc (FEBS)
C1 [Carvalho, F. A.; Martins, I. C.; Faustino, A. F.; Castanho, M.; Santos, N. C.] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.
   [Carneiro, F. A.; Assuncao-Miranda, I.; Mohana-Borges, R.; Da Poian, A. T.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Borges, Ronaldo S Mohana/C-5575-2013; Carvalho, Filomena A./M-9202-2013;
   CARNEIRO, FABIANA A/S-4525-2018; Martins, Ivo C/G-2534-2013; Santos,
   Nuno/N-7248-2013
OI Carvalho, Filomena A./0000-0001-6088-3894; Martins, Ivo
   C/0000-0002-9284-8599; Santos, Nuno/0000-0002-0580-0475
CR Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Martins, 2012, BIOCH J IN PRESS
NR 2
TC 1
Z9 1
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD SEP
PY 2012
VL 279
SU 1
SI SI
BP 10
EP 11
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 996XR
UT WOS:000308128600039
DA 2020-12-01
ER

PT J
AU Carvalho, FA
   Carneiro, FA
   Martins, IC
   Assuncao-Miranda, I
   Faustino, AF
   Pereira, RM
   Bozza, PT
   Castanho, MARB
   Mohana-Borges, R
   Da Poian, AT
   Santos, NC
AF Carvalho, Filomena A.
   Carneiro, Fabiana A.
   Martins, Ivo C.
   Assuncao-Miranda, Iranaia
   Faustino, Andre F.
   Pereira, Renata M.
   Bozza, Patricia T.
   Castanho, Miguel A. R. B.
   Mohana-Borges, Ronaldo
   Da Poian, Andrea T.
   Santos, Nuno C.
TI Dengue Virus Capsid Protein Binding to Hepatic Lipid Droplets (LD) Is
   Potassium Ion Dependent and Is Mediated by LD Surface Proteins
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; C VIRUS; CORE PROTEIN; GOLD NANOPARTICLES;
   ASSOCIATION; REVEALS; CHANNEL; DOMAIN; FORMS; AFM
AB Dengue virus (DENY) affects millions of people, causing more than 20,000 deaths annually. No effective treatment for the disease caused by DENV infection is currently available, partially due to the lack of knowledge on the basic aspects of the viral life cycle, including the molecular basis of the interaction between viral components and cellular compartments. Here, we characterized the properties of the interaction between the DEW capsid (C) protein and hepatic lipid droplets (LDs), which was recently shown to be essential for the virus replication cycle. Zeta potential analysis revealed a negative surface charge of LDs, with an average surface charge of -19 mV. The titration of LDs with C protein led to an increase of the surface charge, which reached a plateau at +13.7 mV, suggesting that the viral protein-LD interaction exposes the protein cationic surface to the aqueous environment. Atomic force microscopy (AFM)-based force spectroscopy measurements were performed by using C proteinfunctionalized AFM tips. The C protein-LD interaction was found to be strong, with a single (un)binding force of 33.6 pN. This binding was dependent on high intracellular concentrations of potassium ions but not sodium. The inhibition of Na+/K+-ATPase in DEW-infected cells resulted in the dissociation of C protein from LDs and a 50-fold inhibition of infectious virus production but not of RNA replication, indicating a biological relevance for the potassium-dependent interaction. Limited proteolysis of the LD surface impaired the C protein-LD interaction, and force measurements in the presence of specific antibodies indicated that perilipin 3 (TIP47) is the major DEW C protein ligand on the surface of LDs.
C1 [Carvalho, Filomena A.; Martins, Ivo C.; Faustino, Andre F.; Castanho, Miguel A. R. B.; Santos, Nuno C.] Univ Lisbon, Inst Mol Med, Fac Med, P-1200 Lisbon, Portugal.
   [Carneiro, Fabiana A.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.
   [Carneiro, Fabiana A.] Univ Fed Rio de Janeiro, Duque De Caxias, Brazil.
   [Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo Goes, Rio De Janeiro, Brazil.
   [Pereira, Renata M.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Bozza, Patricia T.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Santos, NC (corresponding author), Univ Lisbon, Inst Mol Med, Fac Med, P-1200 Lisbon, Portugal.
EM nsantos@fm.ul.pt
RI Carvalho, Filomena A./M-9202-2013; Santos, Nuno/N-7248-2013; Da Poian,
   Andrea T./V-1699-2019; Martins, Ivo C/G-2534-2013; Borges, Ronaldo S
   Mohana/C-5575-2013; CARNEIRO, FABIANA A/S-4525-2018
OI Carvalho, Filomena A./0000-0001-6088-3894; Santos,
   Nuno/0000-0002-0580-0475; Martins, Ivo C/0000-0002-9284-8599; Bozza,
   Patricia/0000-0001-8349-9529; Carneiro, Fabiana/0000-0002-6584-4875;
   FCCN, Bogus/0000-0001-6282-8004; FCCN, Bogus/0000-0003-1034-3552; Da
   Poian, Andrea/0000-0002-3969-704X; Faustino, Andre
   F./0000-0002-7364-8524; Castanho, Miguel/0000-0001-7891-7562
FU European UnionEuropean Union (EU); Fundacao para a Ciencia e a
   Tecnologia-Ministerio da Educacao e Ciencia (FCT-MEC, Portugal)
   [PTDC/QUI-BIQ/112929/2009, PTDC/QUI/69937/2006]; Fundacao Calouste
   Gulbenkian (Portugal); FCT-CAPES Portugal-Brazil; Conselho Nacional de
   Desenvolvimento Cientifico e TecnolOgico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Fundacao Carlos Chagas
   Filho de Anwar a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Financiadora de Estudos e Projetos (FINEP)Ciencia
   Tecnologia e Inovacao (FINEP); National Institute of Science and
   Technology in Dengue (INCT-Dengue); Marie Curie International Outgoing
   FellowshipEuropean Union (EU) [MC-IOE-237373]; FCT-MEC
   [SFRH/BPD/46324/2008, SFRH/BPD/74287/2010]
FX This work was supported by FP7-PEOPLE IRSES (International Research
   Staff Exchange Scheme) project MEMPEPACROSS (European Union), by the
   Fundacao para a Ciencia e a Tecnologia-Ministerio da Educacao e Ciencia
   (FCT-MEC, Portugal) (projects PTDC/QUI-BIQ/112929/2009 and
   PTDC/QUI/69937/2006), by Fundacao Calouste Gulbenkian (Portugal), by the
   FCT-CAPES Portugal-Brazil joint cooperation projects, and by the
   Brazilian funding agencies Conselho Nacional de Desenvolvimento
   Cientifico e TecnolOgico (CNPq), Fundacao Carlos Chagas Filho de Anwar a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ), Financiadora de Estudos e
   Projetos (FINEP), and National Institute of Science and Technology in
   Dengue (INCT-Dengue). I. C. Martins also acknowledges consecutive
   postdoctoral funding from a Marie Curie International Outgoing
   Fellowship (MC-IOE-237373) and FCT-MEC postdoctoral fellowships
   (SFRH/BPD/46324/2008 and SFRH/BPD/74287/2010). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955
   Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469
   Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200
   Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0
   Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200
   Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005
   Brasaemle DL, 1997, J LIPID RES, V38, P2249
   Brewer SH, 2005, LANGMUIR, V21, P9303, DOI 10.1021/la050588t
   Carvalho FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018167
   Carvalho FA, 2010, ACS NANO, V4, P4609, DOI 10.1021/nn1009648
   Conceicao TM, 2010, J VIROL METHODS, V163, P1, DOI 10.1016/j.jviromet.2009.10.001
   Conceicao TM, 2010, J INFECTION, V60, P65, DOI 10.1016/j.jinf.2009.10.003
   Desmeules P, 2002, BIOPHYS J, V82, P3343, DOI 10.1016/S0006-3495(02)75674-9
   Digel M, 2010, FEBS LETT, V584, P2168, DOI 10.1016/j.febslet.2010.03.035
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Domingues MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008385
   Francius G, 2009, NAT PROTOC, V4, P939, DOI 10.1038/nprot.2009.65
   Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6
   Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018
   Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582
   Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Kaufman ED, 2007, LANGMUIR, V23, P6053, DOI 10.1021/la063725a
   Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lee CK, 2007, MICRON, V38, P446, DOI 10.1016/j.micron.2006.06.014
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106
   Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608
   Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912
   McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012
   Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Muller DJ, 2008, BIOCHEMISTRY-US, V47, P7986, DOI 10.1021/bi800753x
   Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001
   Piramowicz MD, 2006, ACTA BIOCHIM POL, V53, P93
   Premkumar A, 2005, J MEMBRANE BIOL, V204, P33, DOI 10.1007/s00232-005-0744-9
   Ratto TV, 2006, LANGMUIR, V22, P1749, DOI 10.1021/la052087d
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Santos NC, 2004, BIOPHYS CHEM, V107, P133, DOI 10.1016/j.bpc.2003.09.001
   Sha BD, 1997, NAT STRUCT BIOL, V4, P239, DOI 10.1038/nsb0397-239
   Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200
   Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009
   Tsapikouni TS, 2010, COLLOID SURFACE B, V75, P252, DOI 10.1016/j.colsurfb.2009.08.041
   Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009
   Wang K, 2011, BBA-BIOMEMBRANES, V1808, P510, DOI 10.1016/j.bbamem.2010.05.006
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Willemsen OH, 2000, BIOPHYS J, V79, P3267, DOI 10.1016/S0006-3495(00)76559-3
   Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200
   Xu ZW, 2010, BIOL PHARM BULL, V33, P743, DOI 10.1248/bpb.33.743
NR 50
TC 79
Z9 79
U1 0
U2 24
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2012
VL 86
IS 4
BP 2096
EP 2108
DI 10.1128/JVI.06796-11
PG 13
WC Virology
SC Virology
GA 886OA
UT WOS:000299862500019
PM 22130547
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Cavalcanti, MG
   Mesquita, JS
   Madi, K
   Feijo, DF
   Assuncao-Miranda, I
   Souza, HSP
   Bozza, MT
AF Cavalcanti, Marta G.
   Mesquita, Jacilene S.
   Madi, Kalil
   Feijo, Daniel F.
   Assuncao-Miranda, Iranaia
   Souza, Heitor S. P.
   Bozza, Marcelo T.
TI MIF Participates in Toxoplasma gondii-Induced Pathology Following Oral
   Infection
SO PLOS ONE
LA English
DT Article
ID MIGRATION-INHIBITORY FACTOR; SMALL-INTESTINE; PERORAL INFECTION;
   HOST-RESISTANCE; C57BL/6 MICE; IFN-GAMMA; MACROPHAGE; CYTOKINE;
   NECROSIS; CELLS
AB Background: Macrophage migration inhibitory factor (MIF) is essential for controlling parasite burden and survival in a model of systemic Toxoplasma gondii infection. Peroral T. gondii infection induces small intestine necrosis and death in susceptible hosts, and in many aspects resembles inflammatory bowel disease (IBD). Considering the critical role of MIF in the pathogenesis of IBD, we hypothesized that MIF participates in the inflammatory response induced by oral infection with T. gondii. Methodology/Principal Findings: Mif deficient (Mif(-/-)) and wild-type mice in the C57Bl/6 background were orally infected with T. gondii strain ME49. Mif(-/-) mice had reduced lethality, ileal inflammation and tissue damage despite of an increased intestinal parasite load compared to wt mice. Lack of MIF caused a reduction of TNF-alpha, IL-12, IFN-gamma and IL-23 and an increased expression of IL-22 in ileal mucosa. Moreover, suppressed pro-inflammatory responses at the ileal mucosa observed in Mif(-/-) mice was not due to upregulation of IL-4, IL-10 or TGF-beta. MIF also affected the expression of matrix metalloproteinase-9 (MMP-9) but not MMP-2 in the intestine of infected mice. Signs of systemic inflammation including the increased concentrations of inflammatory cytokines in the plasma and liver damage were less pronounced in Mif(-/-) mice compared to wild-type mice. Conclusion/Significance: In conclusion, our data suggested that in susceptible hosts MIF controls T. gondii infection with the cost of increasing local and systemic inflammation, tissue damage and death.
C1 [Cavalcanti, Marta G.; Mesquita, Jacilene S.; Feijo, Daniel F.; Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Dept Imunol, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil.
   [Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil.
   [Cavalcanti, Marta G.] Univ Fed Rio de Janeiro, Serv Doencas Infecciosas & Parasitarias, Rio De Janeiro, Brazil.
   [Souza, Heitor S. P.; Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Dept Clin Med, Lab Multidisciplinar Pesquisa, Rio De Janeiro, Brazil.
   [Madi, Kalil] Univ Fed Rio de Janeiro, Dept Patol, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Madi, Kalil] Lab Sergio Franco, Rio De Janeiro, Brazil.
RP Cavalcanti, MG (corresponding author), Univ Fed Rio de Janeiro, Dept Imunol, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil.
EM cavalcanti.marta66@gmail.com; mbozza@micro.ufrj.br
RI Ferreira Feijo, Daniel/Y-6067-2018; de Souza, Heitor Siffert
   Pereira/G-3297-2012
OI de Souza, Heitor Siffert Pereira/0000-0002-3647-7324; Bozza,
   Marcelo/0000-0003-3683-7550
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); Pronex (Programa de Apoio a Nucleos de
   Excelencia - Pronex/FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by CNPq, FAPERJ and Pronex (Programa de Apoio a
   Nucleos de Excelencia - Pronex/FAPERJ
   (www.faperj.br/interna.phtml?ctx_cod = 1.11)). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Assuncao-Miranda I, 2010, J MED VIROL, V82, P164, DOI 10.1002/jmv.21649
   Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469
   Aujla SJ, 2009, J MOL MED, V87, P451, DOI 10.1007/s00109-009-0448-1
   BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0
   Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341
   Brembilla NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018741
   Bucala R, 1996, FASEB J, V10, P1607
   Buzoni-Gatel D, 2006, CELL MICROBIOL, V8, P535, DOI 10.1111/j.1462-5822.2006.00692.x
   CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895
   Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200
   CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0
   Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552
   de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720
   Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569
   Dunne DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011343
   Flores M, 2008, FASEB J, V22, P3661, DOI 10.1096/fj.08-111666
   Garg P, 2009, AM J PHYSIOL-GASTR L, V296, pG175, DOI 10.1152/ajpgi.90454.2008
   Gazzinelli RT, 1996, J IMMUNOL, V157, P798
   Gomes AD, 2011, AM J PATHOL, V178, P2792, DOI 10.1016/j.ajpath.2011.02.005
   He XX, 2009, MOL MED, V15, P1, DOI 10.2119/molmed.2008.00107
   Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497
   Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785
   Kompalic-Cristo A, 2007, PARASITOL RES, V101, P619, DOI 10.1007/s00436-007-0524-9
   Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006
   Liesenfeld O, 1999, PARASITE IMMUNOL, V21, P365, DOI 10.1046/j.1365-3024.1999.00237.x
   Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5
   Magalhaes ES, 2007, EUR J IMMUNOL, V37, P1097, DOI 10.1002/eji.200635968
   Magalhaes ES, 2009, FASEB J, V23, P1262, DOI 10.1096/fj.08-124248
   McDevitt MA, 2006, J EXP MED, V193, P1
   Mennechet FJD, 2002, J IMMUNOL, V168, P2988, DOI 10.4049/jimmunol.168.6.2988
   Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007
   Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574
   Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x
   Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900
   Neves ES, 2009, MEM I OSWALDO CRUZ, V104, P393, DOI 10.1590/S0074-02762009000200039
   Nickdel MB, 2004, PARASITE IMMUNOL, V26, P75, DOI 10.1111/j.0141-9838.2004.00686.x
   Ohkawara T, 2006, IMMUNOL LETT, V107, P148, DOI 10.1016/j.imlet.2006.09.002
   Paiva CN, 2009, J LEUKOCYTE BIOL, V85, P855, DOI 10.1189/jlb.0108009
   Pakozdi A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2021
   Ramirez JM, 2010, EUR J IMMUNOL, V40, P2450, DOI 10.1002/eji.201040461
   Reischl U, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-7
   Reyes JL, 2006, INFECT IMMUN, V72, P3571
   Roberts CW, 1996, INFECT IMMUN, V64, P897, DOI 10.1128/IAI.64.3.897-904.1996
   Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a
   Satoskar AR, 2001, INFECT IMMUN, V69, P906, DOI 10.1128/IAI.69.2.906-911.2001
   Suzuki Y, 2000, J IMMUNOL, V164, P5375, DOI 10.4049/jimmunol.164.10.5375
   Tait ED, 2009, MEM I OSWALDO CRUZ, V104, P201, DOI 10.1590/S0074-02762009000200013
   Terrazas CA, 2010, EXP PARASITOL, V126, P348, DOI 10.1016/j.exppara.2010.03.009
   Ferro EAV, 2008, AM J PATHOL, V172, P50, DOI 10.2353/ajpath.2008.070432
   Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105
   Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083
   Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893
NR 54
TC 26
Z9 26
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 22
PY 2011
VL 6
IS 9
AR e25259
DI 10.1371/journal.pone.0025259
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 825IJ
UT WOS:000295265100077
PM 21977228
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Assuncao-Miranda, I
   Amaral, FA
   Bozza, FA
   Fagundes, CT
   Sousa, LP
   Souza, DG
   Pacheco, P
   Barbosa-Lima, G
   Gomes, RN
   Bozza, PT
   Da Poian, AT
   Teixeira, MM
   Bozza, MT
AF Assuncao-Miranda, Iranaia
   Amaral, Flavio A.
   Bozza, Fernando A.
   Fagundes, Caio T.
   Sousa, Lirlandia P.
   Souza, Danielle G.
   Pacheco, Patricia
   Barbosa-Lima, Giselle
   Gomes, Rachel N.
   Bozza, Patricia T.
   Da Poian, Andrea T.
   Teixeira, Mauro M.
   Bozza, Marcelo T.
TI Contribution of macrophage migration inhibitory factor to the
   pathogenesis of dengue virus infection
SO FASEB JOURNAL
LA English
DT Article
DE MIF; cytokine; lipid droplets; inflammation; hemorrhagic fever; sepsis
ID FACTOR MIF; HEMORRHAGIC-FEVER; JAPANESE ENCEPHALITIS; CHEMOKINE
   RECEPTORS; DISEASE SEVERITY; INNATE IMMUNITY; REGULATORY ROLE;
   SHOCK-SYNDROME; SEPTIC SHOCK; SERUM-LEVELS
AB Dengue fever is an emerging viral disease transmitted by arthropods to humans in tropical countries. Dengue hemorrhagic fever (DHF) is escalating in frequency and mortality rates. Here we studied the involvement of macrophage migration inhibitory factor (MIF) in dengue virus (DENV) infection and its pathogenesis. Patients with DHF had elevated plasma concentrations of MIF. Both leukocytes from these patients and macrophages from healthy donors infected in vitro with DENV showed a substantial amount of MIF within lipid droplets. The secretion of MIF by macrophages and hepatocytes required a productive infection and occurred without an increase in gene transcription or cell death, thus indicating active secretion from preformed stocks. In vivo infection of wildtype and mif-deficient (Mif(-/-)) mice demonstrated a role of MIF in dengue pathogenesis. Clinical disease was less severe in Mif(-/-) mice, and they exhibited a significant delay in lethality, lower viremia, and lower viral load in the spleen than wild-type mice. This reduction in all parameters of severity on DENV infection in Mif(-/-) mice correlated with reduced proinflammatory cytokine concentrations. These results demonstrated the contribution of MIF to the pathogenesis of dengue and pointed to a possible beneficial role of neutralizing MIF as an adjunctive therapeutic approach to treat the severe forms of the disease.-Assuncao-Miranda, I., Amaral, F. A., Bozza, F. A., Fagundes, C. T., Sousa, L. P., Souza, D. G., Pacheco, P., Barbosa-Lima, G., Gomes, R. N., Bozza, P. T., Da Poian, A. T., Teixeira, M. M., Bozza, M. T. Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection. FASEB J. 24, 218-228 (2010). www.fasebj.org
C1 [Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Assuncao-Miranda, Iranaia; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med, Rio De Janeiro, Brazil.
   [Assuncao-Miranda, Iranaia; Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Inst Microbiol, Dept Imunol, BR-21941 Rio De Janeiro, Brazil.
   [Amaral, Flavio A.; Fagundes, Caio T.; Souza, Danielle G.] Univ Fed Minas Gerais, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Bozza, Fernando A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Intens Care Unit, Rio De Janeiro, Brazil.
   [Pacheco, Patricia; Barbosa-Lima, Giselle; Gomes, Rachel N.; Bozza, Patricia T.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, Brazil.
RP Teixeira, MM (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Ave Antonio Carlos,6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM mmtex@icb.ufmg.br; mtbozza@gmail.com
RI Da Poian, Andrea T./V-1699-2019; Gomes, Rachel N/I-7643-2013; Fagundes,
   Caio/AAK-9336-2020; Teixeira, Mauro M/A-4587-2008; Bozza, Fernando
   A/A-2618-2013; Amaral, Flavio/D-5489-2014; souza, danielle/D-3378-2014;
   Amaral, Flavio Almeida/C-3768-2018
OI Fagundes, Caio/0000-0002-6747-5233; Teixeira, Mauro
   M/0000-0002-6944-3008; Bozza, Fernando A/0000-0003-4878-0256; Amaral,
   Flavio/0000-0002-1695-0612; Amaral, Flavio Almeida/0000-0002-1695-0612;
   Bozza, Marcelo/0000-0003-3683-7550; Bozza, Patricia/0000-0001-8349-9529;
   Da Poian, Andrea/0000-0002-3969-704X
FU Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq;
   Brazil)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ; Brazil)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); National Institute of Science and
   Technology in Dengue (INCT-Dengue; Brazil)
FX This work was supported by Conselho de Desenvolvimento Cientifico e
   Tecnologico (CNPq;Brazil), Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ; Brazil), and National Institute of Science and
   Technology in Dengue (INCT-Dengue; Brazil).
CR Amin MA, 2006, BLOOD, V107, P2252, DOI 10.1182/blood-2005-05-2011
   Arjona A, 2007, J CLIN INVEST, V117, P3059, DOI 10.1172/JCI32218
   Armstrong ME, 2008, J IMMUNOL, V180, P7125, DOI 10.4049/jimmunol.180.11.7125
   Arndt U, 2002, J VIROL, V76, P9298, DOI 10.1128/JVI.76.18.9298-9306.2002
   Assuncao-Miranda I, 2010, J MED VIROL, V82, P164, DOI 10.1002/jmv.21649
   Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x
   Bacher M, 2002, VIROLOGY, V299, P32, DOI 10.1006/viro.2002.1464
   BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0
   Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567
   Bosch I, 2002, J VIROL, V76, P5588, DOI 10.1128/JVI.76.11.5588-5597.2002
   Bozza FA, 2004, SHOCK, V22, P309, DOI 10.1097/01.shk.0000140305.01641.c8
   Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783
   Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86
   Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341
   BOZZA PT, 2009, BIOCHIM BIOPHYS ACTA, V1791, P40
   CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895
   Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200
   Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262
   CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0
   Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Chen YC, 2002, J VIROL, V76, P9877, DOI 10.1128/JVI.76.19.9877-9887.2002
   El-Bacha T, 2007, BBA-MOL BASIS DIS, V1772, P1158, DOI 10.1016/j.bbadis.2007.08.003
   Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1
   Flores M, 2008, FASEB J, V22, P3661, DOI 10.1096/fj.08-111666
   Frascaroli G, 2009, J IMMUNOL, V182, P477, DOI 10.4049/jimmunol.182.1.477
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa
   Guzman MG, 2008, T ROY SOC TROP MED H, V102, P522, DOI 10.1016/j.trstmh.2008.03.001
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Higa LM, 2008, BBA-PROTEINS PROTEOM, V1784, P1607, DOI 10.1016/j.bbapap.2008.06.015
   HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324
   Kimura K, 2006, CLIN VACCINE IMMUNOL, V13, P415, DOI 10.1128/CVI.13.3.415-419.2006
   Koebernick H, 2002, P NATL ACAD SCI USA, V99, P13681, DOI 10.1073/pnas.212488699
   La Braga E, 2001, MEM I OSWALDO CRUZ, V96, P229, DOI 10.1590/S0074-02762001000200015
   Leng L, 2005, CRIT CARE MED, V33, pS475, DOI 10.1097/01.CCM.0000191278.04636.D8
   Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Magalhaes ES, 2007, EUR J IMMUNOL, V37, P1097, DOI 10.1002/eji.200635968
   Magalhaes ES, 2009, FASEB J, V23, P1262, DOI 10.1096/fj.08-124248
   McDevitt MA, 2006, J EXP MED, V203, P1185, DOI 10.1084/jem.20052398
   Merk M, 2009, J IMMUNOL, V182, P6896, DOI 10.4049/jimmunol.0803710
   Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100
   Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599
   Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102
   Pacheco P, 2002, J IMMUNOL, V169, P6498, DOI 10.4049/jimmunol.169.11.6498
   Paiva CN, 2009, J LEUKOCYTE BIOL, V85, P855, DOI 10.1189/jlb.0108009
   Pan American Health Organization, 2007, NUMB REP CAS DENG DE
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a
   Satoskar AR, 2001, INFECT IMMUN, V69, P906, DOI 10.1128/IAI.69.2.906-911.2001
   Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020
   Souza DG, 2009, P NATL ACAD SCI USA, V106, P14138, DOI 10.1073/pnas.0906467106
   Souza DG, 2002, AM J PATHOL, V160, P1755, DOI 10.1016/S0002-9440(10)61122-4
   Sprong T, 2007, SHOCK, V27, P482, DOI 10.1097/01.shk.0000246898.65692.34
   Suharti C, 2002, THROMB HAEMOSTASIS, V87, P42
   Suzuki T, 2000, BBA-GENE STRUCT EXPR, V1517, P100, DOI 10.1016/S0167-4781(00)00262-1
   Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0
   *WHO, 2002, 117 WHO
   Zhang Wei, 2002, Hepatobiliary Pancreat Dis Int, V1, P577
NR 62
TC 89
Z9 90
U1 0
U2 11
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD JAN
PY 2010
VL 24
IS 1
BP 218
EP 228
DI 10.1096/fj.09-139469
PG 11
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 539DL
UT WOS:000273233600023
PM 19776337
DA 2020-12-01
ER

PT J
AU Assuncao-Miranda, I
   Bozza, MT
   Da Poian, AT
AF Assuncao-Miranda, Iranaia
   Bozza, Marcelo T.
   Da Poian, Andrea T.
TI Pro-Inflammatory Response Resulting From Sindbis Virus Infection of
   Human Macrophages: Implications for the Pathogenesis of Viral Arthritis
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE Sindbis virus; arthritis; macrophage; inflammatory response; macrophage
   migration inhibitory factor
ID MIGRATION-INHIBITORY FACTOR; ROSS-RIVER-VIRUS; ANTI-INTERLEUKIN-6
   RECEPTOR ANTIBODY; RHEUMATOID-ARTHRITIS; OSTEOCLAST DIFFERENTIATION;
   MATRIX METALLOPROTEINASES; SYNOVIAL FIBROBLASTS; POGOSTA DISEASE;
   OCKELBO DISEASE; NECROSIS-FACTOR
AB Several viruses cause acute and chronic joint inflammation in humans, and among them, the alphaviruses are of special interest due to the increasing number of outbreaks in which they are the etiological factor. Sindbis virus (SinV), a member of the Alphavirus genus, is the most widely distributed of all known arboviruses. Although SinV causes arthritis in humans, the molecular and cellular factors that contribute to the pathogenesis of this disease are almost completely unknown. Despite the crucial role of macrophages in the development of arthritis, these cells have not been recognized as potential targets for viruses causing arthritis. In this study, replication of SinV in human macrophages was demonstrated. The infection promoted macrophage activation, leading to the release of macrophage migration inhibitor factor (MIF) from intracellular stores and inducing the expression and secretion of TNF-alpha, IL-1 beta, and IL-6. Production of these cytokines was followed by the expression of matrix metalloproteinases (MMPs) 1 and 3, which could be involved in the articular damage that has been observed in disease induced by SinV. The use of different strategies to block MIF action, including an anti-MIF antibody, the MIF inhibitor ISO-1 and knockout mice for the MIF gene, showed that cytokine secretion and MMP expression during infection were regulated by MIF, suggesting that this cytokine acts in autocrine and paracrine manner upstream in the macrophage activation cascade. Thus, these are remarkable similarities between macrophage responses induced by SinV infection and those observed in rheumatoid arthritis, despite the different etiologies of infectious and autoimmune arthritides. J. Med. Virol. 82:164-174, 2010. (C) 2009 Wiley-Liss, Inc.
C1 [Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med, Program Struct Biol, BR-21941590 Rio De Janeiro, Brazil.
   [Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Dept Immunol, BR-21941590 Rio De Janeiro, Brazil.
RP Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med, Program Struct Biol, Bloco H,2 Andar,Sala 22, BR-21941590 Rio De Janeiro, Brazil.
EM dapoian@bioqmed.ufrj.br
RI Da Poian, Andrea T./V-1699-2019
OI Da Poian, Andrea/0000-0002-3969-704X; Bozza, Marcelo/0000-0003-3683-7550
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX Grant sponsor: Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ); Grant sponsor: Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq).
CR Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469
   Bokarewa M, 2007, SCAND J IMMUNOL, V66, P192, DOI 10.1111/j.1365-3083.2007.01977.x
   Bozza FA, 2004, SHOCK, V22, P309, DOI 10.1097/01.shk.0000140305.01641.c8
   Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341
   Brennan F, 2007, CURR OPIN RHEUMATOL, V19, P296, DOI 10.1097/BOR.0b013e32805e87f1
   Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273
   Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817
   Calabrese LH, 2008, NAT CLIN PRACT RHEUM, V4, P2, DOI 10.1038/ncprheum0679
   Calabrese LH, 2005, INFECT DIS CLIN N AM, V19, P963, DOI 10.1016/j.idc.2005.09.002
   CALISHER CH, 1985, J CLIN MICROBIOL, V22, P566, DOI 10.1128/JCM.22.4.566-571.1985
   Chen YC, 2002, J VIROL, V76, P9877, DOI 10.1128/JVI.76.19.9877-9887.2002
   CLARRIS BJ, 1975, AUST NZ J MED, V5, P450, DOI 10.1111/j.1445-5994.1975.tb03056.x
   Dayer JM, 2003, RHEUMATOLOGY, V42, P3, DOI 10.1093/rheumatology/keg326
   Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165
   ESPMARK A, 1984, AM J TROP MED HYG, V33, P1203, DOI 10.4269/ajtmh.1984.33.1203
   Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5
   FRASER JRE, 1981, AUST NZ J MED, V11, P168, DOI 10.1111/j.1445-5994.1981.tb04226.x
   Heise MT, 2000, J VIROL, V74, P9294, DOI 10.1128/JVI.74.19.9294-9299.2000
   Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313
   Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743
   Javeed A, 2008, INFLAMM RES, V57, P45, DOI 10.1007/s00011-007-7110-6
   KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x
   Kudrin A, 2006, J BIOL CHEM, V281, P29641, DOI 10.1074/jbc.M601103200
   Kurkela S, 2004, EMERG INFECT DIS, V10, P889, DOI 10.3201/eid1005.030689
   Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X
   Laine M, 2000, RHEUMATOLOGY, V39, P1272, DOI 10.1093/rheumatology/39.11.1272
   Laine M, 2004, J INTERN MED, V256, P457, DOI 10.1111/j.1365-2796.2004.01413.x
   Levine Beth, 1994, Trends in Microbiology, V2, P25, DOI 10.1016/0966-842X(94)90341-7
   Lidbury BA, 2000, J INFECT DIS, V181, P27, DOI 10.1086/315164
   Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200
   Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5
   LVOV DK, 1984, LANCET, V2, P399
   Maini RN, 2000, ANNU REV MED, V51, P207, DOI 10.1146/annurev.med.51.1.207
   Mateo L, 2000, INTERVIROLOGY, V43, P55, DOI 10.1159/000025023
   Matsuyama M, 2007, INTERNAL MED, V46, P771, DOI 10.2169/internalmedicine.46.6262
   McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094
   Mitchell KL, 2007, CURR OPIN RHEUMATOL, V19, P278, DOI 10.1097/BOR.0b013e32805e87bf
   Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029
   Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006
   Morrison TE, 2008, J VIROL, V82, P11263, DOI 10.1128/JVI.01352-08
   Morrison TE, 2007, J VIROL, V81, P5132, DOI 10.1128/JVI.02799-06
   Nishimoto N, 2004, ARTHRITIS RHEUM-US, V50, P1761, DOI 10.1002/art.20303
   Onodera S, 2000, J BIOL CHEM, V275, P444, DOI 10.1074/jbc.275.1.444
   Onodera S, 1999, CYTOKINE, V11, P163, DOI 10.1006/cyto.1998.0402
   Park JY, 2007, BULL HOSP JT DIS, V65, pS4
   Radstake TRDJ, 2005, ARTHRITIS RHEUM, V52, P3020, DOI 10.1002/art.21285
   Rulli NE, 2005, PHARMACOL THERAPEUT, V107, P329, DOI 10.1016/j.pharmthera.2005.03.006
   Santos LL, 2006, WIEN MED WOCHENSCHR, V156, P11, DOI 10.1007/s10354-005-0243-8
   Santos LL, 2009, CLIN CHIM ACTA, V399, P1, DOI 10.1016/j.cca.2008.09.014
   SKOGH M, 1982, LANCET, V1, P795
   Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089
   Suhrbier A, 2004, CURR OPIN RHEUMATOL, V16, P374, DOI 10.1097/01.bor.0000130537.76808.26
   Szekanecz Z, 2007, CURR OPIN RHEUMATOL, V19, P289, DOI 10.1097/BOR.0b013e32805e87ae
   TAYLOR RM, 1955, AM J TROP MED HYG, V4, P844, DOI 10.4269/ajtmh.1955.4.844
   Toivanen A, 2008, CURR OPIN RHEUMATOL, V20, P486, DOI 10.1097/BOR.0b013e328303220b
   VANDERSTRAETEN EF, 1995, DIS COLON RECTUM, V38, P172, DOI 10.1007/BF02052446
   Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697
   Zare F, 2004, J IMMUNOL, V172, P5656, DOI 10.4049/jimmunol.172.9.5656
NR 60
TC 36
Z9 36
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JAN
PY 2010
VL 82
IS 1
BP 164
EP 174
DI 10.1002/jmv.21649
PG 11
WC Virology
SC Virology
GA 533GZ
UT WOS:000272813000021
PM 19950249
DA 2020-12-01
ER

PT J
AU Samsa, MM
   Mondotte, JA
   Iglesias, NG
   Assuncao-Miranda, I
   Barbosa-Lima, G
   Da Poian, AT
   Bozza, PT
   Gamarnik, AV
AF Samsa, Marcelo M.
   Mondotte, Juan A.
   Iglesias, Nestor G.
   Assuncao-Miranda, Iranaia
   Barbosa-Lima, Giselle
   Da Poian, Andrea T.
   Bozza, Patricia T.
   Gamarnik, Andrea V.
TI Dengue Virus Capsid Protein Usurps Lipid Droplets for Viral Particle
   Formation
SO PLOS PATHOGENS
LA English
DT Article
ID HEPATITIS-C VIRUS; INFECTIOUS CDNA-CLONES; ALPHA-HELICAL PROTEIN; CORE
   PROTEIN; FLAVIVIRUS KUNJIN; NUCLEAR-LOCALIZATION; RNA-SYNTHESIS;
   TRANSGENIC MICE; IN-VITRO; REPLICATION
AB Dengue virus is responsible for the highest rates of disease and mortality among the members of the Flavivirus genus. Dengue epidemics are still occurring around the world, indicating an urgent need of prophylactic vaccines and antivirals. In recent years, a great deal has been learned about the mechanisms of dengue virus genome amplification. However, little is known about the process by which the capsid protein recruits the viral genome during encapsidation. Here, we found that the mature capsid protein in the cytoplasm of dengue virus infected cells accumulates on the surface of ER-derived organelles named lipid droplets. Mutagenesis analysis using infectious dengue virus clones has identified specific hydrophobic amino acids, located in the center of the capsid protein, as key elements for lipid droplet association. Substitutions of amino acid L50 or L54 in the capsid protein disrupted lipid droplet targeting and impaired viral particle formation. We also report that dengue virus infection increases the number of lipid droplets per cell, suggesting a link between lipid droplet metabolism and viral replication. In this regard, we found that pharmacological manipulation of the amount of lipid droplets in the cell can be a means to control dengue virus replication. In addition, we developed a novel genetic system to dissociate cis-acting RNA replication elements from the capsid coding sequence. Using this system, we found that mislocalization of a mutated capsid protein decreased viral RNA amplification. We propose that lipid droplets play multiple roles during the viral life cycle; they could sequester the viral capsid protein early during infection and provide a scaffold for genome encapsidation.
C1 [Samsa, Marcelo M.; Mondotte, Juan A.; Iglesias, Nestor G.; Gamarnik, Andrea V.] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina.
   [Assuncao-Miranda, Iranaia; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.
   [Barbosa-Lima, Giselle; Bozza, Patricia T.] Fundacao Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, Brazil.
RP Samsa, MM (corresponding author), Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina.
EM agamarnik@leloir.org.ar
RI Da Poian, Andrea T./V-1699-2019
OI Da Poian, Andrea/0000-0002-3969-704X; Bozza,
   Patricia/0000-0001-8349-9529
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute;
   INCT-Dengue
FX This work was funded by Howard Hughes Medical Institute ( International
   Program in Infectious Diseases (http://hhminews.org/research/scholars/
   gamarnik.html). ATDP was supported by the INCT-Dengue. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Accioly MT, 2008, CANCER RES, V68, P1732, DOI 10.1158/0008-5472.CAN-07-1999
   Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014
   AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200
   Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005
   Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x
   Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0
   Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200
   Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005
   Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928
   Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913
   Huerre MR, 2001, VIRCHOWS ARCH, V438, P107
   Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997
   Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001
   Khromykh AA, 1996, ARCH VIROL, V141, P685, DOI 10.1007/BF01718326
   Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500
   Kofler RM, 2003, J VIROL, V77, P443, DOI 10.1128/JVI.77.1.443-451.2003
   Kofler RM, 2002, J VIROL, V76, P3534, DOI 10.1128/JVI.76.7.3534-3543.2002
   Koyama N, 2008, J ANTIBIOT, V61, P509, DOI 10.1038/ja.2008.68
   Kuhajda FP, 2005, TRENDS PHARMACOL SCI, V26, P541, DOI 10.1016/j.tips.2005.09.002
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Lindenbach BD, 2007, FIELDS VIROLOGY, P1101
   Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003
   Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001
   Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608
   Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912
   McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414
   Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Moradpour D, 1996, VIROLOGY, V222, P51, DOI 10.1006/viro.1996.0397
   Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005
   Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527
   Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053
   Namatame I, 2004, P NATL ACAD SCI USA, V101, P737, DOI 10.1073/pnas.0307757100
   NOWAK T, 1989, VIROLOGY, V169, P365, DOI 10.1016/0042-6822(89)90162-1
   Paes MV, 2005, VIROLOGY, V338, P236, DOI 10.1016/j.virol.2005.04.042
   Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07
   Patkar CG, 2007, J VIROL, V81, P6471, DOI 10.1128/JVI.02120-06
   Pijlman GP, 2006, J VIROL, V80, P11255, DOI 10.1128/JVI.01559-06
   Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0
   SCHLICK P, 2009, J VIROL
   Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009
   Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016
   Wang SH, 2004, J GEN VIROL, V85, P2307, DOI 10.1099/vir.0.80067-0
   Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westaway EG, 1997, VIROLOGY, V234, P31, DOI 10.1006/viro.1997.8629
   Westaway EG, 2002, CURR TOP MICROBIOL, V267, P323
   YAMAZAKI H, 2009, J ANTIBIOT TOKYO
   YAMSHCHIKOV VF, 1994, J VIROL, V68, P5765, DOI 10.1128/JVI.68.9.5765-5771.1994
   Zhu W, 2007, VIRUS RES, V126, P226, DOI 10.1016/j.virusres.2007.03.004
   2009, DIS OUTBREAK NEWS
NR 64
TC 321
Z9 324
U1 0
U2 32
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1553-7366
J9 PLOS PATHOG
JI PLoS Pathog.
PD OCT
PY 2009
VL 5
IS 10
AR e1000632
DI 10.1371/journal.ppat.1000632
PG 14
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 522XK
UT WOS:000272033300036
PM 19851456
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Axelband, F
   Assuncao-Miranda, I
   de Paula, IR
   Ferrao, FM
   Dias, J
   Miranda, A
   Miranda, F
   Lara, LS
   Vieyra, A
AF Axelband, Flavia
   Assuncao-Miranda, Iranaia
   de Paula, Isabela R.
   Ferrao, Fernanda M.
   Dias, Juliana
   Miranda, Antonio
   Miranda, Filipe
   Lara, Lucienne S.
   Vieyra, Adalberto
TI Ang-(3-4) suppresses inhibition of renal plasma membrane calcium pump by
   Ang II
SO REGULATORY PEPTIDES
LA English
DT Article
DE Renin-angiotensin system; Ang-(3-4); Angiotensin receptors; Active
   calcium transport; Kidney cells; Basolateral membranes
ID INTERSTITIAL FLUID ANGIOTENSIN; TUBULE NA+-ATPASE; VAL-TYR;
   ANTIHYPERTENSIVE DIPEPTIDE; PROXIMAL TUBULES; CA2+ ATPASE; RECEPTOR;
   TRANSPORT; METABOLISM; PATHWAYS
AB We previously demonstrated that Ang II inhibits the renal plasma membrane Ca2+-ATPase. In the present work we have studied the effect of Ang II, at concentrations similar to those found in the renal interstitium, on the Ca2+-ATPase from proximal tubule cells. High Ang II concentration (5 x 10(-7) mol/L) led to the recovery of Ca2+-ATPase activity previously inhibited by 50% at low Ang II concentration (10(-10) mol/L). Reacdvation occurred in parallel with: (i) formation of only two dead-end metabolites [Ang-(3-4) and Tyr] after incubation of isolated membranes with micromolar Ang II; and (ii) dissociation of constitutive AT(1)R/AT(2)R heterodimers, which are preserved with 10(-10) mol/LAng II. When the membranes were incubated with 10(-14) mol/LAng-(3-4), inhibition by 10(-10) mol/L Ang II was no longer observed. The counteracting effect of Ang-(3-4) was abolished by PD123319, an antagonist of AT(2)R, and mimicked by CGP42112A, an agonist of AT(2)R. Ang-(1-7) is an intermediate in the formation of Ang(3-4) via a pathway involving angiotensin-converting enzyme (ACE), and complete dipeptide breakdown to Tyr and Val is impaired by low Ang II. We conclude that Ang-(3-4) may be a physiological regulator of active Ca2+ fluxes in renal proximal cells by acting within the renin-angiotensin axis. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Axelband, Flavia; de Paula, Isabela R.; Ferrao, Fernanda M.; Dias, Juliana; Miranda, Filipe; Vieyra, Adalberto] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.
   [Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.
   [Miranda, Antonio] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil.
   [Lara, Lucienne S.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
RP Vieyra, A (corresponding author), Cidade Univ, BR-21949900 Rio De Janeiro, Brazil.
EM avieyra@biof.ufrj.br
RI Miranda, Antonio/C-8855-2012; Dias, Juliana/O-7918-2016; Lara, Lucienne
   S./F-5771-2017
OI Lara, Lucienne S./0000-0002-2204-8799
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq); Rio de Janeiro Research
   State Foundation (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Sao Paulo Research
   State Foundation (FAPESP), BrazilFundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP)
FX This work was supported by grants from the Brazilian National Research
   Council (CNPq), the Rio de Janeiro Research State Foundation (FAPERJ)
   and the Sao Paulo Research State Foundation (FAPESP), Brazil. F.A., I.
   A-M., I. R. de P., F.M.F and J.D. were recipients of fellowships from
   CNPq. F.M. was a recipient of a fellowship from the Program "Talented
   Young People" (FAPERJ). A.V. received the grant award "Scientist of our
   State" from FAPERJ. The skillful technical assistance of Gloria
   Costa-Sarmento, the helpful comments by Dr. Robson R. Bernardo regarding
   HPLC analysis and the required corrections of English by BioMedES (UK)
   are also acknowledged. This work is dedicated to Jorge Almeida Guimaraes
   on his 70th birthday.
CR AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200
   AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095
   AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003
   Allred AJ, 2000, AM J PHYSIOL-RENAL, V279, pF841
   Ardaillou R, 1996, B ACAD NAT MED PARIS, V180, P475
   Assuncao-Miranda I, 2005, REGUL PEPTIDES, V127, P151, DOI 10.1016/j.regpep.2004.11.004
   Basso N, 2001, HYPERTENSION, V38, P1246, DOI 10.1161/hy1201.101214
   Bernstein KE, 2001, CONTRIB NEPHROL, V135, P16
   Bouley R, 1998, EUR J PHARMACOL, V343, P323, DOI 10.1016/S0014-2999(97)01549-5
   BOUMENDILPODEVIN EF, 1983, BIOCHIM BIOPHYS ACTA, V728, P39, DOI 10.1016/0005-2736(83)90434-0
   BRAAM B, 1993, AM J PHYSIOL, V264, pF891
   CARAFOLI E, 1991, ANNU REV PHYSIOL, V53, P531, DOI 10.1146/annurev.physiol.53.1.531
   Carey RM, 2008, TRENDS ENDOCRIN MET, V19, P84, DOI 10.1016/j.tem.2008.01.003
   COELHOSAMPAIO T, 1991, J BIOL CHEM, V266, P10249
   COKAGUEVARA S, 1999, EUR J CHEM, V264, P3274
   de Gasparo M, 2000, PHARMACOL REV, V52, P415
   Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026
   Dinh DT, 2001, CLIN SCI, V100, P481, DOI 10.1042/CS20000263
   Du ZP, 2003, AM J PHYSIOL-RENAL, V284, pF688, DOI 10.1152/ajprenal.00261.2002
   GRUBMEYER C, 1981, J BIOL CHEM, V256, P3718
   Haithcock D, 1999, J AM SOC NEPHROL, V10, pS69
   Hakam AC, 2006, AM J PHYSIOL-RENAL, V290, pF1430, DOI 10.1152/ajprenal.00218.2005
   Hakam AC, 2006, HYPERTENSION, V47, P1117, DOI 10.1161/01.HYP.0000220112.91724.fc
   Handa RK, 2000, J AM SOC NEPHROL, V11, P1377
   Harris PJ, 1996, CLIN EXP PHARMACOL P, V23, pS112, DOI 10.1111/j.1440-1681.1996.tb03071.x
   Ingelfinger JR, 1999, AM J PHYSIOL-RENAL, V276, pF218
   Kobayashi Y, 2001, J AM COLL CARDIOL, V37, P1329, DOI 10.1016/S0735-1097(01)01162-7
   Kramkowski K, 2006, J PHYSIOL PHARMACOL, V57, P529
   Lara LD, 2006, BIOCHEM J, V395, P183, DOI 10.1042/BJ20051455
   Lara LS, 2002, REGUL PEPTIDES, V103, P17, DOI 10.1016/S0167-0115(01)00322-6
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Magaldi AJ, 2003, PFLUG ARCH EUR J PHY, V447, P223, DOI 10.1007/s00424-003-1173-1
   MAIA JCC, 1983, GENES ANTIGENES PARA, P146
   MATSUFUJI H, 1995, BIOSCI BIOTECH BIOCH, V59, P1398, DOI 10.1271/bbb.59.1398
   Matsui T, 2005, HYPERTENS RES, V28, P545, DOI 10.1291/hypres.28.545
   Matsui T, 2004, J PEPT SCI, V10, P535, DOI 10.1002/psc.568
   Matsui T, 2003, CLIN EXP PHARMACOL P, V30, P262, DOI 10.1046/j.1440-1681.2003.03824.x
   Matsui T, 2002, CLIN EXP PHARMACOL P, V29, P204, DOI 10.1046/j.1440-1681.2002.03628.x
   Mills N, 1999, SEIZURE-EUR J EPILEP, V8, P1
   Navar LG, 2002, HYPERTENSION, V39, P316, DOI 10.1161/hy0202.103821
   Nishiyama A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000026610.48842.CB
   Nishiyama A, 2002, HYPERTENSION, V39, P129, DOI 10.1161/hy0102.100536
   Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005
   Padia SH, 2006, HYPERTENSION, V47, P537, DOI 10.1161/01.HYP.0000196950.48596.21
   Pentzien AK, 2008, Z NATURFORSCH C, V63, P451
   Rangel LBA, 1999, BBA-BIOMEMBRANES, V1416, P309, DOI 10.1016/S0005-2736(98)00234-X
   SAITO Y, 1994, BIOSCI BIOTECH BIOCH, V58, P1767, DOI 10.1271/bbb.58.1767
   Santos RAS, 2000, REGUL PEPTIDES, V91, P45, DOI 10.1016/S0167-0115(00)00138-5
   Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100
   Shaltout HA, 2007, AM J PHYSIOL-RENAL, V292, pF82, DOI 10.1152/ajprenal.00139.2006
   SIRAGY HM, 1995, HYPERTENSION, V25, P1021, DOI 10.1161/01.HYP.25.5.1021
   SORENSON MM, 1986, J MEMBRANE BIOL, V90, P219, DOI 10.1007/BF01870128
   Su Z, 2006, KIDNEY INT, V69, P2212, DOI 10.1038/sj.ki.5001509
   Tanaka M, 2008, LIFE SCI, V82, P869, DOI 10.1016/j.lfs.2008.02.001
   Tanaka M, 2006, BIOSCI BIOTECH BIOCH, V70, P2292, DOI 10.1271/bbb.60119
   Thomas WG, 2003, INT J BIOCHEM CELL B, V35, P774, DOI 10.1016/S1357-2725(02)00263-7
   van Esch JHM, 2008, EUR J PHARMACOL, V588, P286, DOI 10.1016/j.ejphar.2008.04.042
   van Esch JHM, 2006, BRIT J PHARMACOL, V148, P452, DOI 10.1038/sj.bjp.0706762
   VIEYRA A, 1986, J BIOL CHEM, V261, P4247
   Zhuo JL, 2006, AM J PHYSIOL-RENAL, V290, pF1382, DOI 10.1152/ajprenal.00269.2005
NR 60
TC 13
Z9 13
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-0115
EI 1873-1686
J9 REGUL PEPTIDES
JI Regul. Pept.
PD JUN 5
PY 2009
VL 155
IS 1-3
BP 81
EP 90
DI 10.1016/j.regpep.2009.03.014
PG 10
WC Endocrinology & Metabolism; Physiology
SC Endocrinology & Metabolism; Physiology
GA 463UR
UT WOS:000267458200014
PM 19345245
DA 2020-12-01
ER

PT J
AU Assuncao-Miranda, I
   Guilherme, AL
   Reis-Silva, C
   Costa-Sarmento, G
   Oliveira, MM
   Vieyra, A
AF Assuncao-Miranda, I
   Guilherme, AL
   Reis-Silva, C
   Costa-Sarmento, G
   Oliveira, MM
   Vieyra, A
TI Protein kinase C-mediated inhibition of renal Ca2+ ATPase by
   physiological concentrations of angiotensin II is reversed by AT(1)- and
   AT(2)-receptor antagonists
SO REGULATORY PEPTIDES
LA English
DT Article
DE angiotensin II; plasma membrane Ca2+ ATPase; angiotensin II receptors;
   kidney proximal tubules; renal transport; phosphorylations
ID SARCOPLASMIC-RETICULUM; BASOLATERAL MEMBRANES; CALCIUM MOBILIZATION;
   SODIUM-TRANSPORT; KIDNEY; RECEPTOR; (CA2++MG2+)-ATPASE; ACTIVATION
AB Angiotensin II (Ang II) increases the cytosolic Ca2+ concentration in different cell types. In this study, we investigate the effect of Ang II on the Ca2+ ATPase of purified basolateral membranes of kidney proximal tubules. This enzyme pumps Ca2+ out of the cytosol in a reaction coupled to ATP hydrolysis, and it is responsible for the fine-timed regulation of cytosolic Ca2+ activity. Ca2+-ATPase activity is inhibited by picomolar concentrations of Ang II, with maximal inhibition being attained at approximate to 50% of the control values. The presence of raising concentrations (10(-11) to 10(-7) M) of losartan (an AT(1)-receptor antagonist) or PD123319 (an AT(2)-receptor antagonist) gradually reverts inhibition by Ang H. Both the phospholipase C (PLC) inhibitor U-73122 (10(-6) M) and the inhibitor of protein kinase C (PKC) staurosporine (10-7 M) prevent inhibition of the Ca2+ pump by Ang H. Incubation of the previously isolated membranes with a PKC activator-the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (10(-8) M)-mimics the inhibition found with Ang H, and the effects of the compounds are not additive. Taken as a whole, these results indicate the Ang H inhibits Ca2+-ATPase by activation of a PKC system present in primed state in these membranes after binding of the hormone to losartan- and PD123319-sensitive receptors coupled to a PLC. Therefore, inhibition of the basolateral membrane Ca2+-ATPase by kinase-mediated phosphorylation appears to be one of the pathways by which Ang II promotes an increase in the cytosolic Ca2+ concentration of proximal tubule cells. (C) 2004 Published by Elsevier B.V.
C1 Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil.
   Univ Massachusetts, Sch Med, Worcester, MA 01605 USA.
RP Vieyra, A (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil.
EM avieyra@biof.ufrj.br
CR AnkorinaStark I, 1997, CELL CALCIUM, V21, P163, DOI 10.1016/S0143-4160(97)90040-3
   Balla T, 1998, ENDOCR RES, V24, P335, DOI 10.3109/07435809809032613
   Benesic A, 2000, PFLUG ARCH EUR J PHY, V439, P278, DOI 10.1007/s004240050941
   Bernstein KE, 2001, CONTRIB NEPHROL, V135, P16
   BINDELS RJM, 1993, KIDNEY INT, V43, P295, DOI 10.1038/ki.1993.46
   BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756
   Bouby N, 1997, J AM SOC NEPHROL, V8, P1658
   BOUMENDILPODEVIN EF, 1983, BIOCHIM BIOPHYS ACTA, V735, P86, DOI 10.1016/0005-2736(83)90263-8
   BURNAY MM, 1994, ENDOCRINOLOGY, V135, P751, DOI 10.1210/en.135.2.751
   Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999
   Carey RM, 2000, HYPERTENSION, V35, P155, DOI 10.1161/01.HYP.35.1.155
   Caruso-Neves C, 2000, BBA-BIOMEMBRANES, V1468, P107, DOI 10.1016/S0005-2736(00)00248-0
   CHAKRAVARTHY BR, 1994, BIOCHEM J, V304, P809, DOI 10.1042/bj3040809
   COELHOSAMPAIO T, 1991, J BIOL CHEM, V266, P10249
   Coka-Guevara S, 1999, EUR J BIOCHEM, V263, P71, DOI 10.1046/j.1432-1327.1999.00456.x
   DEGASPARO M, 1995, HYPERTENSION, V25, P924, DOI 10.1161/01.HYP.25.5.924
   Dinh DT, 2001, CLIN SCI, V100, P481, DOI 10.1042/CS20000263
   Du ZP, 2003, AM J PHYSIOL-RENAL, V284, pF688, DOI 10.1152/ajprenal.00261.2002
   El Muayed M, 2004, J CARDIOVASC PHARM, V43, P318
   Feng YH, 1999, J BIOL CHEM, V274, P35546, DOI 10.1074/jbc.274.50.35546
   Feraille E, 2001, PHYSIOL REV, V81, P345
   GMAJ P, 1979, BIOCHEM J, V178, P549, DOI 10.1042/bj1780549
   GRIENDLING KK, 1986, J BIOL CHEM, V261, P5901
   GUILHERME A, 1992, ACTA PHYSIOL SCAND, V146, P223
   Haithcock D, 1999, J AM SOC NEPHROL, V10, pS69
   Harris PJ, 1996, CLIN EXP PHARMACOL P, V23, pS112, DOI 10.1111/j.1440-1681.1996.tb03071.x
   Jagadeesh Gowraganahalli, 1998, Indian Journal of Experimental Biology, V36, P1171
   Jezova M, 2003, ENDOCRINOLOGY, V144, P2092, DOI 10.1210/en.2002-0019
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MENDEZ CF, 1992, ACTA PHYSIOL SCAND, V146, P135, DOI 10.1111/j.1748-1716.1992.tb09401.x
   Purdy KE, 2001, J AM SOC NEPHROL, V12, P19
   Rossier M F, 2000, Vitam Horm, V60, P229, DOI 10.1016/S0083-6729(00)60021-3
   Sharma R, 2001, J LAB CLIN MED, V138, P40, DOI 10.1067/mlc.2001.115493
   SORENSON MM, 1986, J MEMBRANE BIOL, V90, P219, DOI 10.1007/BF01870128
   TAUSSKY HH, 1953, J BIOL CHEM, V202, P675
   VIEYRA A, 1986, J BIOL CHEM, V261, P4247
   Vieyra A, 1996, BIOSCIENCE REP, V16, P115, DOI 10.1007/BF01206201
NR 37
TC 16
Z9 18
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-0115
EI 1873-1686
J9 REGUL PEPTIDES
JI Regul. Pept.
PD APR 15
PY 2005
VL 127
IS 1-3
BP 151
EP 157
DI 10.1016/j.regpep.2004.11.004
PG 7
WC Endocrinology & Metabolism; Physiology
SC Endocrinology & Metabolism; Physiology
GA 897RX
UT WOS:000227023900018
PM 15680481
DA 2020-12-01
ER

EF